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vAbstract
Duplications and deletions are a major source of genomic variation. Duplications,
specifically,  have  a  significant  impact  on  gene  genesis  and  dosage,  and  the  malaria
parasite  P. falciparum has developed resistance to  a growing number of anti-malarial
drugs via gene duplication. It also contains highly duplicated families of antigenically
variable  allelic  genes.  While  specific  genes  and  families  have  been  studied,  a
comprehensive analysis of duplications and deletions within the reference genome and
population has not been performed. We analyzed the extent of segmental duplications
(SD)  in  the  reference  genome  for  P.  falciparum,  primarily  by  a  whole  genome  self
alignment. We discovered that while 5% of the genome identified as SD, the distribution
within  the  genome  was  partition  clustered,  with  the  vast  majority  localized  to  the
subtelomeres.  Within  the  SDs,  we  found  an  overrepresentation  of  genes  encoding
antigenically diverse proteins exposed to the extracellular membrane, specifically the var,
rifin, and stevor gene families. To examine variation of duplications and deletions within
the parasite  populations,  we designed a  novel  computational  methodology to identify
copy  number  variants  (CNVs)  from high  throughput  sequencing,  using  a  read  depth
based approach refined with discordant read pairs. After validating the program against in
vitro lab cultures, we analyzed isolates from Senegal for initial tests into clinical isolates.
We then expanded our search to a global sample of 610 strains from Africa and South
East  Asia,  identifying  68  CNV regions.  Geographically,  genic  CNV were  found  on
vi
average  in  less  than  10% of  the  population,  indicating  that  CNV are  rare.  However,
CNVs at high frequency were almost  exclusively duplications associated with known
drug resistant CNVs. We also identified the novel biallelic duplication of the crt gene –
containing both the chloroquine resistant and sensitive allele. The synthesis of our SD
and CNV analysis  indicates a CNV conservative  P. falciparum  genome except where
drug and human immune pressure select for gene duplication.
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1CHAPTER I: Introduction
21.1 Genomic Duplications and Deletions
Duplications and deletions are the gain and loss of nucleotide sequence in the
genome.  Genomic  duplications  are  a  significant  means  of  genetic  adaptation  found
through all organisms. The duplication and deletion of genic content is conducive to rapid
gene dosage control, genesis of new gene function, and diversification of function within
a gene family. However, the change in gene expression from duplications and deletions is
not without consequence, and can be subject to significant selective pressures for fixation
or removal from the population. This results in genetic copy changes that are transient
and highly  variable  within  the population  of  the organism,  resulting in  copy number
variation.
During evolution,  genes are often subject  to copy number changes,  whether a
duplication or deletion of the gene  [1]. The size of the region affected can range from
single genes to entire chromosomes  [1, 2]. A copy number change has immediate short
term ramifications, specifically on gene dosage, but over time, can result in new functions
arising as mutations occur  [3]. While deletions usually have deleterious effects and are
rarely propagated, duplications have a number of possible evolutionary end points  [4].
The evolutionary fate of duplications is dependent on the selective pressures on the gene.
In situations where increased protein production confers an advantage, gene duplication
is a simple means to provide increased protein production, as it doubles the available
transcribable  nucleotide  sequence.  It  is  also  a  more  rapid  means  to  control  gene
expression than through nucleotide substitution as  the gene duplication rate  has  been
3found to be significantly higher than the per nucleotide substitution rate  [5]. This has
been a  significant  area  of  investigation  due  the  effect  increased  gene  dosage  has  on
pathogen drug resistance.
A primary effect of gene duplication is increased gene dosage (Figure 1.1)  [6].
Given positive selection,  the duplication can become fixed in the population,  and the
copies will both remain highly conserved  [7]. Changes in gene dosage is an important
means of mutability and adaptability for organisms  [8]. Commonly,  it  is  a means for
pathogenic  resistance  to  chemotherapy,  such  as  the  duplication  of  blaSHV-11 gene  in
Klebsiella  pneumoniae for  increased  amoxicillin  resistance  [9].  The  increased  gene
dosage can also be present to compensate for another deleterious mutation. For example,
resistance  to  actinonin,  a  peptide  deformylase  inhibitor,  arises  via  mutations  to
methionyl-tRNA formyltransferase and incurs a large fitness disadvantage in the absence
of actinonin [10]. In the absence of actinonin pressure, duplications are rapidly removed
from the gene pool due to incurred fitness disadvantages. However, gene duplications to
metZ and metW genes have been shown to mitigate the fitness disadvantage of actinonin
resistance  [11]. Gene dosage change by duplication is a rapid, compared to nucleotide
substitution, and effective reaction to various selective pressures.
The balance of gene dosage is typically at an effective equilibrium, and so the
genome is resistant to many changes in gene regulation. Therefore, if the increased gene
dosage has overall a deleterious effect, it results in the rapid removal of the duplication
from  the  population  [3].  With  little  to  no  selective  pressure  to  maintain  the  gene
duplication, the fate of duplicated genes is loss from the population due to deleterious
4Figure 1.1 The effects of gene duplication. A) Gene duplication results in increased
gene dosage, as the duplication of a gene directly results in increased protein production
of the gene. B) Over time, one copy of a gene duplication may accrue enough mutations
to produce a protein with a new function. This results in a reversion to previous gene
dosage levels and an increase in potential functionality.

6selection  or  loss  through  random drift  [12].  If  a  gene  is  maintained,  often  silencing
mutations  occur  that  result  in  the pseudogenization  of  the gene.  More  rarely  relaxed
selective pressures on the gene dosage change can maintain the duplication for the gain of
advantageous mutations and new function [13–15].
A new function can evolve by one of two courses: subfunctionalization or neo-
functionalization (Figure 1.2)  [16]. In subfunctionalization, accumulation of mutations
results in the combination of both copies providing the original and necessary function
[16–18].  This  decouples  the  domains  or  the  original  gene,  resulting  in  dependent
evolutionary trajectories and further specialization of functions. Neofunctionalization is
the more common fate for duplicated genes that are not silenced  [15]. In the case of
neofunctionalization, one copy attains new functionality separate from the original copy
[15, 19]. This provides an important avenue for genetic adaptation [4]. Evidence indicates
that the new copy, if not silenced, will undergo rapid and asymmetric mutation [13, 15,
20]. Recent evidence supports neofunctionalization as the more common means of new
gene specialization and gain of function over subfunctionalization [13]. This indicates an
importance in the maintenance of original gene copy function. Neofunctionalization can
result in large duplicated gene families with diverse or redundant functionality  [1, 21].
This is especially evident in gene families undergoing diversifying selection, such as the
human olfactory receptor contingent  [22, 23]. It  is  also a common means to increase
antigen diversity in pathogens, including the malaria parasite Plasmodium falciparum. P.
falciparum's  ability  to  chronically  infect  the human is  thought  to  account  for  a large
repertoire of diverse antigens to counter the human immune response  [24].  Increased
7Figure 1.2 Subfunctionalization and neofunctionalization of gene duplication. A) The
equivalent  loss  of  function  rate  between  two  duplicated  genes  results
subfunctionalization. The two duplicate genes have specialized in various functions of the
ancestral gene. B) The asymmetric loss of function between two duplicate genes and the
gain  of  new  function  of  one  of  the  duplicates  is  the  typical  course  of  action  for
neofunctionalization.
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9diversity and redundancy in function can provide a greater fitness advantage.
Numerous studies have investigated the extent of duplications and deletions to
better  understand  the  impact  of  the  subsequent  genetic  diversity  on  fitness  [25–29].
Genomic  duplications  are  an  avenue  of  genetic  adaptation  found  in  all  types  of
organisms. They provide a means for rapid gene dosage control, genesis of new gene
function, and diversification of function within a gene family. However, the genetic copy
changes are also very transient and so are affected strongly by purifying selection  [3].
This makes detection of these copy number changes difficult.
1.2 Detection of Duplications and Deletions
Duplications and deletions are difficult  phenomena to detect  and for which to
delineate lineage. However, current sequencing efforts have made it possible to detect
ancient  and recent  copy number changes  [30,  31].  With the advent  of  complete  high
quality  reference  genomes  [32,  33],  comparison  within  the  reference  genome  and
between species has made the delineation of duplications and deletions possible [34, 35].
Array comparative genomic hybridization (array CGH) and high throughput sequencing
technologies have also made it possible to detect genome wide copy number variation
[30]. Detection of these duplications and deletions aids in understanding past and current
evolutionary pressures [36].
Duplications and deletions leave behind evidence of their existence in the genome
– the sequence itself. Segmental duplications are blocks of normal genomic DNA that
occur  more  than  once  within  the  genome,  such as  the  tracts  of  duplicated  sequence
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composing  much  of  the  mammalian  repertoire  of  olfactory  genes  [37].  Segmental
duplications are identified by regions of high similarity sequence within the genome. We
can  infer  regions  of  duplication  and  fixation  from the  divergence  of  sequence,  with
greater divergence related to greater likelihood of fixation. Segmental duplications can
point to sequence in the genome that may still be undergoing variation in the greater
population. For example, mammalian genomes have shown a large expansion of olfactory
genes, but in primates the extent of duplication of olfactory genes has been decreasing
[36].  Segmental  duplications are  most  easily  via self-alignment  of sequence from the
reference genome, either with amino acid or nucleotide sequence [38–40]. However, only
duplications can be reliably detected. Without related species for comparison, deletions of
genomic  regions  leave  little  trace  of  their  occurrence.  Species  specific  duplication  is
difficult to determine from more ancient duplication without cross comparison between
genomes  [41].  High  similarity  sequence  between  species  can  identify  potential
orthologous  genes  between  the  species  and  paralogous  genes  within  the  species.
Examination of what genes are duplicated is important for understanding the evolutionary
pressures  upon  duplications  after  speciation  [42].  Using  sequence  data  from  related
species, we can also detect deletion events in our species of interest [36].
Genomes are not static, and the continual production of duplications and deletions
means that genomes are constantly in flux. The resultant variation caused by periodic
genomic  duplication  and deletion  is  referred  to  as  copy number  variation.  These  are
duplications and deletions that have not become fixed throughout the population, and so
vary between individual genomes. These genetic copy change events are in the midst of
11
either fixation for gene dosage advantages, silencing, or neo- and subfunctionalization
[43]. Currently, the capabilities exist to rapidly detect copy number variations genome-
wide  between  individuals  [44].  This  can  be  done  either  with  array  CGH  or  high
throughput sequencing, making it possible to survey entire populations for copy number
variation. Surveying populations for copy number variation can identify variants between
individuals, potentially highlighting a fitness advantage to these copy number variations
[45].
Currently, there are methods for the detection of duplications and deletions, both
ancient and recent. These methods involve either self-alignment of the reference genome
or read depth analysis of multiply aligned sequences against the reference genome [31,
46, 47]. The analysis of these duplications and deletions provides important insight into
the evolutionary pressures at work. These insights are not only important to understand
evolutionary forces at work on the human genome [48], but also play an important role in
pathogenic genomes [49]. Of great interest is the pathogenic parasite P. falciparum. The
sheer scale and rapidity of population P. falciparum turnover results in duplications and
deletions  having  an  important  and  rapid  role  in  adaptation.  Genetic  duplications  are
extensively used by pathogenic agents for diversification of whole gene families for the
purpose of evasion of the human immune system, P. falciparum included. In addition, the
mounting selective pressure from chemotherapeutic therapies has increased the role of
gene dosage control by genetic copy number variation in P. falciparum [50, 51]. This has
spurred increased efforts to rapidly survey P. falciparum populations to 1) understand the
extent of known drug resistance-related CNVs and 2) identify previously unknown drug
12
resistance-related CNVs.
1.3 Plasmodium falciparum
In P. falciparum, a human malaria parasite, the duplication and deletion of genes
is a major means of adaptation  [52]. Malaria is a global epidemic, responsible for an
estimated 219 million cases and 660,000 deaths a year [53]. It primarily affects tropical
areas and developing nations. Greater than 90% of malaria related mortalities are caused
by  Plasmodium falciparum [53].  In  addition  to  the  mortality  totals  it  inflicts,  it  also
significantly impacts local economies, both due to the health care burden and the loss of
work time at  all  ages from recurrent infection  [54]. This species is distributed in the
tropics worldwide, but the majority of cases occur in Sub-Saharan Africa. Children tend
to suffer disproportionately from the most serious clinical syndromes of  P. falciparum
[53].
The life cycle of P. falciparum involves two hosts, both the mosquito vector and
the human host (Figure 1.3). Both aspects of its life cycle involve points of significant
duplication of the genome,  indicating points  of  potential  recombination and therefore
duplication and deletion of parts of the genome. There are four points in the life cycle of
P.  falciparum where  asexual  duplication  of  the  genome occurs  to  produce  numerous
progeny, in addition to sexual reproduction between a male and female gametes. Upon
uptake of blood from a human host of P. falciparum, the sexual reproductive cycle occurs
between parasites. Male gametocytes undergo further duplication of the genome to 8N
ploidy,  before  subsequently  dividing  into  eight  haploid  gametes  [55].  Fertilization
13
Figure 1.3 Life cycle of the malaria parasite P. falciparum.
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between  a  male  and  female  gamete  results  in  a  diploid  zygote,  which  will  undergo
genome duplication to become tetraploid ookinetes  [56]. Eventual differentiation of the
zygote  to  an  oocyst  and  then  the  sporogony of  thousands  of  sporozoites  [57].  From
gametocyte to sporozoite, the P. falciparum parasite traverses from the mosquito midgut
to the salivary glands [58]. The sporozoites infect the human host from the saliva of the
mosquito during a blood meal [59].
Upon infection by mosquito bite, the sporozoite infects hepatocytes, starting the
life cycle of the P. falciparum parasite in the human host [59]. Within the hepatocytes, the
sporozoite matures further until schizogony, resulting in serial duplications of the genome
and subsequent release of thousands of merozoites upon lysis of the hepatocyte [56]. The
merozoites infect  erythrocytes to enter  the erythrocyte stage of the  P. falciparum life
cycle. During this erythrocytic cycle, the parasite undergoes asexual reproduction during
schizogony to produce about  16 duplicated genomes  [60].  These schizonts eventually
divide into individual merozoites to reinfect a new erythrocyte and begin the cycle anew
[61].
Untreated,  the erythrocytic  stage  is  the longest  stage in  the  P. falciparum life
cycle.  Despite treatment being widely available and prescribed, asymptomatic malaria
still remains a major reservoir of long term P. falciparum infection [62]. The long term
infection of  P. falciparum in the erythrocytic cycle, which can exceed 3 years, requires
significant diversity of extracellularly exposed parasite proteins [63]. These proteins are
targeted by the human immune system and so are under significant selective pressure by
the human immune system for diversification. The proteins during the erythrocytic cycle
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that have the most time exposed extracellularly are found in large gene families with
significant nucleotide diversity, and therefore significant amino acid diversity [64]. This
may  be  a  prominent  reason  for  the  constant  recurrent  infections  –  the  high  antigen
diversity from the large and heavily duplicated gene families of under strong selective
pressure for diversity from evasion of the human immune system [64]. The life cycle of
the malaria parasite involved numerous points of genomic duplication and recombination,
each of which provides the necessary conditions establishment of duplication within the
haploid genome. 
1.4 Duplications and Deletions in Plasmodium falciparum
While  many  chemotherapeutic  solutions  have  been  developed  over  the  years,
developing drug resistance has materialized for current mainstream therapies, many via
duplication of particular alleles  [65–67].  Genetic  duplications have been shown to be
important in the arms race against human immune system and chemotherapeutic agents.
Large gene families undergo diversifying selection for antigenic evasion [68]. There have
been numerous studies on gene duplications for increased drug resistance  [50, 69, 70].
Large deletions of entire arms of chromosomes have been identified as adaptation to in
vitro culturing  of  the  parasites  [71].  However,  the  extent  of  duplication  fixation  and
variation between strains has not been systematically investigated.
Large  gene  families  within  the  P.  falciparum genome  are  borne  of  ancient
duplication events [64]. The consecutive duplications of an ancestral gene were generated
out of necessity for diversification or novelty of function. One of the major examples of
17
this  is  the  var gene  family  [72].  Proteins  coded  by  these  genes  are  inserted  in  the
erythrocyte membrane and are responsible for the subsequent binding to the endothelial
lining, thereby sequestering the infected erythrocyte in post-capillary venules  [73]. As
deformability of the erythrocyte decreases during maturation of the P. falciparum parasite
during infection of the erythrocyte, the sequestration of the parasite into post-capillary
venules by the var genes prevents splenic filtration of infected erythrocytes and parasite
destruction  [74]. There are a number of similar gene families, such as  rifin and  stevor
genes [75], which have functions in other aspects of the parasite life cycle. stevor genes
are implicated in the rosetting of erythrocytes and mediation of merozoite invasion [76].
While there are numerous studies analyzing the sequence similarity within these gene
families  [77, 78], little has been done to holistically examine the duplication profile of
these genes. Most work has excluded surrounding genes and sequence. All these gene
families exist within the same regions of the genome, primarily the subtelomeres [79]. As
gene duplications rarely occur for singular genes, multiple genes are often duplicated
[80]. The extent of duplication in P. falciparum has not been studied systematically. We
perform a systematic analysis of copy number variation and segmental duplications in the
fully  sequenced  genome of  P.  falciparum,  identifying  high  sequence  identity  regions
throughout the genome by a BLAST-like self-alignment.  Gene ontology trends,  GC%
bias, and the potential means of sequence diversification between the large gene families
are explored.
In  this  work,  segmental  duplications  identified  from a  high  quality  reference
genome denote duplications found within the reference genome. We performed a self-
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alignment based process of the  P. falciparum 3D7 reference genome to identify these
segmental  duplications.  From  this,  we  identified  regions  of  high  identity  and  likely
duplications. While many of these duplications may be fixed in the overall P. falciparum
population, many may not be fixed. Duplications and deletions are a continual process, so
there may be significant variation of gene duplication and deletion between strains of P.
falciparum [70,  80].  These  copy  number  variations  are  typically  short  term  gene
duplications as adaptations against selective pressure. The most prominent examples have
been in copy number variation linked to drug resistance.  PFE1150w, PFL1155w, and
PFD0830w are all gene whose amplification has been linked to drug resistance [50, 69,
70]. Multiple classes of drugs are affected by these gene amplifications including anti-
folates and 4-amino-quinolones. In addition, there are known copy number variations that
are side effects of adaptation to in vitro cell culture of parasites, having roles in growth
fitness [52, 71].
Many of the copy number variations identified were through select quantitative
PCR experiments on likely gene targets [69, 81, 82]. There have been attempts to provide
a  genome  wide  systematic  test  for  copy  number  variations  –  via  array  comparative
genomic hybridization (array CGH) and high throughput sequencing [83–86]. However,
the difficulty of working with a highly AT biased genome composition with significant
tracts  of  simple  sequence  has  made  surveying  the  extent  of  copy  number  variation
throughout the natural P. falciparum population a difficult endeavor. Most genome wide
analysis involves  in vitro cell cultured lab strains, both with array CGH and next gen
sequencing. Despite numerous methods to leverage high throughput sequencing for copy
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number  variation  detection  in  P.  falciparum [84–86],  there  have  been  no  published
experiments to identify copy number variation from a large cohort of field isolates of P.
falciparum. This is partly due to the significant AT bias of the genome, which mitigates
the  ability  to  specifically  identify  copy  number  variation  from  high  throughput
sequencing. To identify copy number variation in natural populations of  P. falciparum,
we  developed  a  custom  computational  methodology  to  leverage  high  throughput
sequencing data to sensitively and specifically identify copy number variations in the
genome. We tested this program on a publicly available sample of unique P. falciparum
strains from Senegal to test the validity of our method [87]. In addition, we investigate
the genome wide analysis of copy number variation from over 600 publicly available
high throughput sequencing datasets  from Africa and South East Asia:  Burkina Faso,
Cambodia, Gambia, Ghana, Guinea, Kenya, Mali,  Senegal, and Thailand  [87–91]. We
determine that copy number variation in P. falciparum is rare within the population, and
we also discovered  a  number  of  novel  copy number  variations  -  with  potential  drug
resistance implications or growth adaptations.
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2.1 Introduction
Duplication of genomic DNA is a long recognized route for the creation of novel
genes  [92].  Duplications can be categorized based on various metrics such as length,
location, gene content, or mechanism of transposition. A primary categorization is often
performed by length, ranging from duplication of the entire chromosomal complement
(whole genome duplication or polyploidy), through duplication of a single chromosome
(aneuploidy), to duplication of small portions of chromosomes (segmental duplication),
which  can range from hundreds to millions of bases in size. Segmental duplications are
also often described on the basis of their functional content (gene, partial gene, or exon)
or  in  terms  of  the  relative  location  (intrachromosomal  versus  intrachromosomal  and
tandem  versus  interspersed).  Segmental  duplications  can  occur  through  multiple
mechanisms, of which aberrant non-allelic homologous recombination, or breakage and
repair events through non-homologous end joining are the most common [93–95].
Initial studies of gene evolution through duplication have focused on the role of
large-scale  whole  genome  duplications  that  left  signatures  of  massive  gains  and
alterations in the total gene complement [92, 96, 97]. While further studies have shown
strong  evidence  in  both  yeast  and  vertebrates  for  ancient  rounds  of  whole  genome
duplication  [96,  98,  99],  the  advent  of  the  Human Genome Project  and high-quality
reference  genomes  [32] also  have  led  to  the  renewed  recognition  of  segmental
duplications as the most prevalent, recent, and continuous source of gene evolution [100,
101]. Segmental duplications can have differing biological consequences. An immediate
22
impact  from any duplication  event  of  a  gene  or  other  functional  element  is  that  the
activity  or  dosage can be increased  [6].  Segmental  duplication followed by sequence
divergence  allows  for  the  evolution  of  new  and  diverse  functions  [15].  This  is  of
particular  importance  for  countering  the  breadth  of  environmental  and  pathogen
exposures. For example, human genes within segmental duplications are highly enriched
for histocompatability antigens [102].  Alternatively, duplications in pathogens are often
associated  with  virulence  or  diversification  of  extracellularly  exposed  proteins  for
immune evasion  [29, 98, 103]. In pathogens,  duplications also provide an avenue for
rapid  gene  dosage  response  to  drug  pressure  for  which  P.  falciparum has  multiple
examples (e.g. mdr1, gch)[70, 104]. Thus, duplications provide plasticity in an organism
allowing  for  the  evolution  of  new  or  diversified  responses  to  an  everchanging
environment. 
Segmental duplications also create dynamic regions within the genome due to
high  sequence  identity  that  can  promote  misalignment  and  non-allelic  homologous
recombination  (NAHR),  resulting  in  further  duplication,  deletion,  or  potentially  more
complex arrangements [105, 106]. Misalignment can equally lead to gene conversion, a
phenomenon implicated in increasing the diversity within segmental duplications  [107].
Thus, duplicated regions in the genome can rapidly evolve and diversify in response to
evolutionary pressure.
Duplicated regions have practical consequences for genome analysis as they are
more  difficult  to  assemble.  Even  with  high-quality  reference  genomes,  improper
alignment  of  reads  because of  duplicated  high  similarity  regions  have  effects  on  the
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downstream analysis  causing problems with correctly  identifying SNPs, copy number
variants,  etc.  In  addition,  graph  based  de  novo genome  assemblies  with  next  gene
sequencing  can  collapse  at  these  regions  of  high  similarity,  preventing  contiguous
assembly  of  these  regions  of  the  genome.  Knowing  what  regions  contain  segmental
duplications  and  the  scale  of  similarity  can  inform future  experiments  for  adjusting
downstream analysis to account for the segmental duplications. 
In malaria,  segmental  duplication plays an important  role  within the causative
pathogen, Plasmodium. Malaria is a disease with an estimated 219 million cases per year
and an estimated 660,000 deaths [53].  Similar to many other pathogens – Plasmodium
spp.,  piroplasms,  coccidians  and  Cryptosporidium spp. -  duplicated  gene  families  of
Apicomplexa are predominantly found in the subtelomeric and telomeric regions of the
chromosomes and have a predilection toward antigenic variation for immune evasion
[25].  There  have  been  extensive  studies  into  the  structure  of  the  subtelomeric  and
telomeric  regions  of the  P. falciparum genome resulting in a general  structure of the
subtelomeric regions [33, 108–110]. Of particular interest within these regions have been
the large gene families of extracellularly exposed proteins involved in cytoadherence –
rifins, stevors, and vars [75, 111, 112]. The var genes are singly expressed genes involved
in the endothelial sequestration of the parasite during blood stage [113]. These genes have
been studies extensively for their  antigenic variation  [78, 111]. They show significant
copy number variation between strains and within monoclonal cultures – both in vivo and
in vitro [111]. The molecular mechanism of variability and duplication of the var genes
has been attributed to gene conversion [31, 114].
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While many insights have been gained from such targeted analyses, a complete
picture of the pattern and nature of segmental duplications within P. falciparum can be of
great biological and practical use. Such an analysis will allow us to better understand the
genomic constraints and evolutionary forces at play. Here we apply established methods
for  genome-wide  detection  of  segmental  duplications  and  characterize  their  salient
properties and patterns.
2.2 Methods
Segmental duplication detection
We refined and  applied  two well-established  methods  for  detecting  segmental
duplications, whole-genome alignment comparison (WGAC) and whole-genome shotgun
sequence detection (WSSD), which have both been used extensively in larger eukaryotic
genomes [31, 47, 84, 102]. Both methods make use of a high quality reference genome.
For  both  WGAC  and  WSSD,  we  used  P.  falciparum 3D7  reference  genome  from
PlasmoDB  v9.3.  Our  WGAC  analysis  for  segmental  duplication  detection  employs
openly  available  alignment  software,  sequence  analysis  software,  and  custom  Perl
programs modified from previous work as outlined in Figure 2.1 and detailed in Bailey et
al.  [31]. The overall methodology for any genome consists of (1) removing high copy
repeats  that  represent  simple  tandem  repeats  and  transposable  elements,  (2)  local
alignment of the entire “repeat-free” genome to itself to detect similar regions above a
given  identity  and  length,  (3)  reinsertion  of  the  high  copy  repeats,  and  (4)  refining
(trimming/extending) the termini of alignments to locate the most accurate end point. If
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Figure  2.1  Overview  of  segmental  duplication  identification  by  self-alignment.
Tandem repeats and simple repeat sequence were identified with Tandem Repeat Finder
and RepeatMasker. The identified repeat sequences were spliced from the genome, and
LASTZ was used to identify high identity alignments with a custom substitution matrix
from this modified genome. Repeat sequences were spliced back into the genome. With
custom  scripts,  we  heuristically  extended  alignment  to  incorporate  spliced  repeat
sequences.  Finally,  a  global  alignment  of  the  pairwise  alignments  was  used  to  more
accurately delineate alignments.
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unrecognized  transposable  elements  are  not  a  contaminating  issue,  then  the  final
alignments represent a database of recent segmental duplications (Figure 2.1). For this
work,  WGAC  methods  were  specifically  updated  and  modified  to  improve  pipeline
speed,  robustness,  as  well  as  to  address  specific  characteristics  of  the  P.  falciparum
genome – smaller size, abundance of tandem repeats, and highly elevated AT content (GC
% 18%) [33]. Specifically for this analysis, the P. falciparum genome (version PlasmoDB
9.3) was analyzed for tandem repeats and low-complexity regions using Tandem Repeat
Finder (version 4.04) [115] and RepeatMasker version 3.2.9 [116], respectively.  The lack
of  known  transposable  elements  within  the  genome  abrogated  the  need  for  their
characterization with RepeatMasker. Large-tandem repeats (period 50-350 and copies ≥5
via Tandem Repeat Finder), and low-complexity sequence (100bp regions  ≥87% AT or
≥89% GC with  a  30bp stretch  of  29 AT or  GC nucleotides  via  RepeatMasker)  were
spliced out of the chromosomes and local alignments were generated within and between
all  chromosomes.  Improvements  to  the  previous  methods  included  replacing  slower
NCBI BLAST with LASTZ [117] and using a custom scoring matrix to account for the
GC bias during the alignment process (Table 2.1). This scoring matrix was calculated
using the described methods [118] from a representative subset of initial alignments >250
bp  and  >88%  identity  generated  using  a  3,8  match/mismatch  LASTZ  scoring.  The
optimized matrix  produced a  greater  median segmental  duplication  length (1,480 bp)
compared  to  non-custom  LASTZ  scoring  parameters  (222  bp).  The  custom  match
parameters also detected more alignments and with higher average identities (Figure 2.2).
Coordinates  of  LASTZ  alignments  lacking  repeats  were  translated  back  into
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Table 2.1 LASTZ custom substitution matrix. Self-alignments from LASTZ with flat
match/mis-match scoring between  >80% identity and >250 bp were used to create the
custom substitution matrix. Log-odds scores between the paralogs were calculated and
averaged to generate the custom LASTZ substitution matrix.
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  Match Base
A T C G
A 2 -9 -7 -13
Query T -9 13 -1 -5
Base C -7 -1 11 -8
G -12 -5 -10 4
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Figure 2.2 LASTZ custom substitution scoring outperforms flat match/mis-match
scoring. A)  The  custom  substitution  matrix  produces  significantly  more  pairwise
alignments  as  alignment  size  grows  as  compared  to  a  flat  match/mis-match  scoring
system. B) The custom substitution matrix identifies a significantly higher number of low
percent identity alignments than the flat match/mis-match scoring system, though both
are comparable at identifying high identity regions.
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normal genomic coordinates, effectively reinserting the previously removed tandem and
simple  sequence  repeats.  The  alignment  end  points  were  refined  to  more  accurately
determine the extent of segmental duplication which might terminate within an adjacent
tandem or simple sequence repeat. This was accomplished heuristically through iterative
extension of the global alignment up to 2 kbp and redetermination of the alignment end
point.  This  was  iterated  until  end  point  convergence.  After  refinement,  final  optimal
global alignments were kept if  ≥250bp and  ≥90% bp identity. Lastly, to yield our final
analysis  set,  pairwise  alignments  with  juxtaposed  and  properly  oriented  and  ordered
copies were merged across up to 2 kb gaps, in order to more completely capture likely
segmental  duplication  events  even  if  subsequent  large  insertions  or  deletions  have
occurred over time within the individual copies.
WSSD is a method exploiting whole-genome shotgun sequence reads as a random
sample of the genome such that increasing density of reads in a region relative to the
genome average directly correlates with increased number of copies.  Illumina whole-
genome shotgun sequence for the reference genome strain 3D7 [119] were mapped with
bowtie2 to the PlasmoDB 9.3 3D7 reference genome assembly [33, 120]. Sequence files
for PCR-free Illumina GAII 3D7 libraries can be accessed at SRA archive SRP056541. In
separate analyses, alignments were performed both with single best and multiple (up to
100) best placements within the genome. Samtools was used to determine read depth per
base  position  in  the  genome  [121].  To  remove  GC sequencing  biases,  we  applied  a
correction factor for each 100bp window baed on a LOESS correction of read depth
against GC% [122]. Regions of potential duplication were defined by tiling windows of
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1,000bp with a median read depth ≥2 and tandem repeat content <70%. Windows were
merged to generate contiguous regions of elevated read depth indicative of more than one
copy  within  the  genome.  These  regions  were  compared  to  detect  probable  assembly
errors, either the false positive or false negative identification of segmental duplications
from WGAC.
Descriptive statistics of pairwise alignments
All  identified  pairwise  alignments  ≥90% identity  and  ≥250 bp  were  analyzed
either  at  the  level  of  pairwise  alignment  or  based on non-redundant  coverage  of  the
genome. We determined a measure for the most recent duplication event by the highest
percent identity pairwise alignment present in each base in the genome. Due to the high
nucleotide diversity between some genes with segmental duplications, particularly the
var genes, a requirement for the complete intersection of a gene with an alignment did
not accurately capture the extent of genic content within segmental duplications. Many
genes  had  little  to  no  self-alignment  with  any  other  regions  of  the  genome,  yet  the
flanking regions of these genes show evidence of duplication. Therefore genes with any
portion of their coding regions or ±50 bp of the flanking regions of the gene having an
aligned pair were cataloged. Gene information was obtained from PlasmoDB gff files –
PlasmoDB 9.3. Genes included in the segmental duplications were analyzed in GOSTAT
to determine under and overrepresented gene ontology (GO) terms [123]. Visualization of
segmental duplications was performed using Parasight [124].
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Analysis of segmental duplications around var and rifin genes
Pairwise alignments often did not include the interior of the var genes, which is
due  to  the  gene-families  high  nucleotide  diversity  [64].  We  analyzed  the  pairwise
alignments on either side of the  var gene (up to 50 bp away from the gene itself) to
extend the  pairwise  alignment.  The  pairwise alignments  flanking the  var gene were
identified, and examined for whether the pairwise alignments paired with the same gene
elsewhere in the genome. This would identify the extent of whole gene duplication and
gene conversion within the vars. The same methods were also applied to the rifin gene
contingent.
2.3 Results
Detection of pairwise alignments representing segmental duplications
We further optimized the whole genome alignment comparison (WGAC) to detect
segmental duplications within the reference P. falciparum 3D7 genome. WGAC is a well-
established method which  initially  seeds  on putatively  unique  sequence  by removing
high-copy repeats from the sequence leaving putatively unique sequence.  Repeats are
then reinserted and alignment edges are then refined to capture the precise extent of any
pairwise alignments. Global alignments are then calculated to provide the most accurate
measures of pairwise identity. A total  of 2,579 pairwise alignments (median length of
2,005 bp) were found at an alignment threshold of  ≥90% identity and  ≥250  bp. These
alignments covered 5.93% (1,380,021bp / 23,292,622bp) of the genome (Figure 2.3).
The WSSD analysis is sensitive for highly-similar segmental duplications  [102,
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Figure  2.3  Overview  of  segmental  duplications  in  the  genome. We  identified
duplicated  sequence  as  alignments  ≥250 bp in  size  and ≥90% sequence  identity  and
aligned them to the genome. The map shows the overlay of segmental duplications on the
genome,  split  into  interchromosomal  and  intrachromosomal  segmental  duplications).
Interchromosomal  (red)  duplications  are  depicted  above  the  chromosome.
Intrachromosomal (blue) duplications are depicted below the chromosome. Gene content
is demarcated in black along the chromosome, with exceptions for var genes (green) and
rifin genes (purple). Tick marks are at every 500 kb interval.
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125] and was highly concordant with the WGAC alignments ≥95% identity.  There was
one  exception  greater  than  250  bp  (Figure  2.4)  where  WSSD  detected  a  known
duplication of gch1 (PFL1155w) related to anti-folate resistance  [70]. Overall,  WSSD
supports that the 3D7 genome is a high quality and accurate reference genome assembly
in respect to duplication.
Genomic distribution of segmental duplications
Segmental duplications localized predominantly to the telomeric and subtelomeric
regions  of  almost  every  chromosome  (Figure  2.4).  The  vast  majority  of  duplication
outside  of  the  subtelomeric  regions  were  associated  with  clusters  of  extracellularly
exposed  genes  under  human  immune  pressure.  Overall,  only  129  kb  (0.6%  of  the
genome) of the duplicated sequence were not associated with either the subtelomeres or
extracellularly located proteins. Thus, given this highly skewed distribution, the amount
of segmental duplications between chromosomes appeared to correlate with the size of
the  subtelomeric  regions  and  cytoadherence  complement  rather  than  the  overall
chromosomal  length.  This  can  be  seen  in  that  the  amount  of  segmental  duplication
content per chromosome remained relatively similar across chromosomes and was not
correlated with chromosome size (Figure 2.5).  However,  a  chi-squared test  showed a
statistically  significant  difference  in  the  goodness  of  fit  for  duplicated  space  per
chromosome (p-value = 8.79x10-70) indicating some variability. Chromosome 5 stands out
as  it  was  over  2 standard deviations  (σ  = 2.11)  from the  mean duplicated space per
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Figure 2.4 Comparison of WSSD to WGAC for segmental duplication identification.
A map of all high read depth regions in the genome >1,000 bp and <70% tandem repeat
content as determined by WSSD (above chromosome in red) is compared to our WGAC
method at >95% bp similarity (below chromosome in blue).
39
40
Figure 2.5 Duplication content between chromosomes. A) The cumulative lengths of
the highest pairwise identity at all loci of duplication - i.e. reducing to the unique highest
identity  pairwise  alignments  –  also  indicates  small  variation  between  the  various
chromosomes. B) Duplicated fraction of the chromosome. Chromosome 4 and 13 stand
out for their relative enrichment of intrachromosomal duplication – caused by the high
identity  tandemly  duplicated  clusters  of  var genes  internal  to  the  chromosome.  The
duplicated fraction of the chromosome decreases with chromosome size, indicating the
duplicated space is unlinked with chromosome size.
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chromosome.  Most  other  chromosomes  (9  chromosomes)  were  within  1  standard
deviation of the mean, with all other chromosomes under 2 standard deviations.
We examined the relative rates of intra versus interchromosomal duplication to
determine  any  biases  for  intrachromosomal  duplications  versus  interchromosomal
duplications, as tandem duplication of genomic sequence is common. We performed a
binomial  test  assuming  the  probability  for  an  intrachromosomal  duplication  to  be
dependent  on  the  number  of  chromosomes  (expected  probability  =  7.14%),  as  the
duplicated space was approximately the same across chromosomes. The binomial test for
all  identified  segmental  duplications  showed  there  was  no  statistically  significant
difference  between  intrachromosomal  and  interchromosomal  duplications  (observed
probability  =  7.10%,  p-value  =  0.9694).  However,  a  binomial  test  for  high  identity
segmental  duplications  (≥98%)  showed  a  statistically  significant  difference  with  an
observed probability of 16.4% (p-value = 3.73x10-4), indicating that the majority of all
segmental duplications had no bias toward intra- or interchromosomal duplications but
the high identity duplications were enriched for tandem duplications.
Gene content of segmental duplications
There  were  466  genes  and  pseudogenes  out  of  5,772  in  the  genome  that
intersected regions of identified segmental duplications. 81 of those were  var genes or
pseudogenes and 164 were  rifins, comprising the majority of genes in their respective
families – 101 and 185 respectively. While often overlooked, rifins actually represent the
most abundant gene family [112] and contain many recent highly-identical duplications.
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In addition to the the vars and rifins, another gene family has been associated with the
subtelomeric  regions  –  stevors [75].  Previous  reports  with  unfixed  copy  number
variations  indicate  that  nucleotide  diversity  was  elevated  in  duplications  [83].  Our
analysis  verifies  this  claim  as  the  enrichment  of  these  antigenic  genes  in  segmental
duplications  resulted  in  increased  nucleotide  diversity  within  segmental  duplications.
From a collated list of nucleotide diversity of genes, we determined that genes located
within segmental duplications have elevated nucleotide diversity (two sided t-test, t-value
= 2.271, p = 0.0237) [126]. 
Outside of the sub-telomeric regions and internal  var clusters, we identified 17
genic intrachromosomal pairwise alignments and 10 genic interchromosomal pairwise
alignments (only one pair required to be outisde sub-teolmeric regions). Of these 27, 25
had pairwise alignments that completely spanned the gene(s). The largest group of genes
to be duplicated were 10 rRNAs. This is in accordance with the expansion of rRNAs and
subsequent divergence for life cycle specific expression and function [127]. Other genes
including reticulocyte binding proteins, falcipain 2, elongation factor 1-α, var trafficking,
SERA, CLAG, and ubiquitin. PFL0585w, did not have complete coverage of pairwise
alignment, but it showed a significant number of pairwise alignments all along its genic
content.  As  a  polyubiquitin,  it  was  successive  tandem  duplications  of  the  ubuquitin
domain in Pf13_0346.
Consistent with their localization to the subtelomeres, segmental duplications had
a lower mean GC% of 18.74% compared to the genomic mean of 19.4% (one sample
two-sided t-test against genome mean, p =7.97e-10). After a duplication event, mutations
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will have caused paralogs to diverge  [13]. If mutations rates were regular, the percent
identity could be used as a surrogate of relative age and could provide insight into the
tempo of segmental duplication over time. When alignments were categorized by percent
identity, there was an abundance of pairwise alignments at lower identity (Figure 2.6).
However,  when  only  the  highest  identity  pairwise  per  loci  were  examined,  which
provides a better correlate of events when accounting for repeated duplications of the
same loci, the quantity of duplicated sequence appeared more uniform across levels of
percent identity. This suggested that the drivers and processes of duplication has been
relatively continuous rather than punctuated process.
Extracellularly exposed genes overrepresented in segmental duplications
We  performed  ontological  analysis  of  the  genes  intersecting  with  segmental
duplications.  Of the overrepresented GO terms,  most  were related to  extraorganismal
interaction - i.e. extra-organismal space, interaction between organisms, extracellular, etc
- while GO terms related to normal cell function are underrepresented - i.e. metabolic
activity, cell signaling. Excluding vars, rifins, and stevors genes, segmentally duplicated
genes had no over or under representation of GO terms. 46 of these 100 genes were
hypothetical proteins with no known function, however 13 were rRNA associated. Of
those 100 genes, 70 of them overlapped high identity segmental duplications, indicating a
reduction  in  relaxed  selective  pressure  on  these  genes  as  compared  to  genes  in  the
subtelomeric regions.
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Figure  2.6  Duplication  content  by  percent  similarity. The  cumulative  lengths  of
pairwise alignments per 1% ranges in identity were binned for A) all pairwise alignments
and B) the highest pairwise identity at all loci of duplication – i.e. the reducing to unique
highest identity pairwise alignments. The shape of the graphs indicate that the rate of
duplication is has likely been relatively consistent over time based on the fact that many
pairwise alignments represent repeated duplication of the same region. 
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The nature of var and rifin gene segmental duplications
The majority  of  var genes  lacked pairwise  alignments  that  spanned the  entire
gene.  This appeared to be a  consequence of high nucleotide diversity within exon 1,
which  could  be  a  consequence  of  rapid  divergence  through  positive  selection  or  a
consequence of an elevated rate of gene conversion. To examine these possibilities, we
focused on  the  highest  identity  alignments  across  each  var gene  (Figure  2.7).   This
revealed that most var genes have divergent pairwise alignments flanking the genes – i.e.
each side of the var gene best identifies with a different var gene. Of the 81 var genes,
only  29  (35%)  genes  had  flanking  pairwise  alignments  match  to  the  same  var gene
(Figure 2.7a), and only 5 (6%) genes had pairwise alignments that spanned the entire
gene (Figure 2.7c). The genes lacking matching alignments consisted of  39 (48%) genes
(Figure 2.7b) where flanking alignments mapped to different var genes in the genome,
and 12 genes where the other end did not have evidence of a matching gene.
The other large gene family,  rifins, were analyzed similarly. While rifins show
similar evidence of a high rate of duplication, with 90% of  rifin genes having pairwise
alignments  intersecting and 100% of  var genes.  However,  the  rifin genes were more
likely to have a spanning pairwise alignment, 33% of rifin genes had a spanning pairwise
alignment as opposed to 6% of var genes. When looking at the highest identity alignment
for the flanking of rifin genes, show similar levels of cross mapping of alignments with
106 (58%) of the rifin genes had the highest pairwise alignment on either end of the rifin
pair to different rifin genes, while only 55 (30%) genes had alignments on either side that
matched  to  same  rifin gene.  This  pattern  suggests  a  strong  role  for  non-duplicative
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Figure  2.7  Model  of  possible  duplication  patterns  for virulence  genes. Virulence
related genes,  vars and  rifins, display three distinct patterns of duplication across their
respective gene families. A) A spanning duplication of the virulence gene 1, but time and
high nucleotide variation of the genes themselves has prevented an spanning alignment of
the duplication. B) Gene conversion within virulence gene 1 has resulted in a hybrid of
both virulence gene 2 and virulence gene 3 ancestry. This results in the highest identity
location of pairwise alignments on either side of virulence gene 1 to point to different
virulence  genes.  C)  A complete  high  identity  pairwise  alignment  of  entire  an  entire
virulence gene.
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processes such as conversion or telomeric exchanges hybridizing in the genesis of these
duplications relative to strict duplication followed by rapid divergence.
2.4 Discussion
We analyzed the  P. falciparum reference 3D7 strain P.  falciparum genome for
segmental  duplications  via  whole  genome  alignment  comparison.  We  validated  the
sensitivity of the whole genome alignment comparison with a whole genome shotgun
sequence detection approach.  The analysis  with whole genome alignment comparison
highlighted that the vast majority of segmentally duplicated sequence was located within
the sub-telomeric regions of the genome or within var gene clusters. Consequently, genes
within  the  segmental  duplications  were  overrepresented  for  extracellularly  exposed
genes, particularly the var and rifin genes, which appeared based on our analysis, to be
evolving through duplicative mechanisms combined with partial exchange methods, such
as gene conversion, creating genes of chimeric origin. Overall, the segmental duplications
have been sequestered mainly in the sub-telomeric space of the genome leaving a core
genome that is relatively staid and lacking in significant standing duplication. 
Our systematic analysis of segmental duplications in the  P. falciparum genome
confirmed that the subtelomeric regions have been highly duplicated, and the region is
the major source of segmental duplications in the genome. The vast majority of genes in
the segmental duplications were related to antigen presenting proteins. Except for tandem
duplication in non-subtelomeric  var clusters, segmental duplications did not show any
significant preference for intrachromosomal duplication. This seemed to indicate a mostly
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random duplication of genes through relatively unbiased subtelomeric interaction.
Analysis of pairwise alignments can be challenging to interpret because they do
not correlate one to one, as the pairwise representation increase rapidly with repeated
duplication of a given sequence. Direct examination of the pairwise alignments shows a
prominent abundance below 95% identity. This abundance markedly decreases when only
the most recent segmental duplication in a region are examined. This suggests that there
vars and rifins are likely under constant amplification with genes being gained and lost.
These genes appear to be continually evolving based on the broad distribution of pairwise
identities and that antigenic diversification has likely been a more continuous, rather than
punctuated,  process  vis-a-vis host  immune evasion.  Additionally,  there  appears  to  be
significant  amounts  of  conversion  or  hybridization  taking  place,  in  addition  to
diversifying mutation.   
Conversely, segmental duplications are nearly absent from the rest of the genome.
There is little trace of duplication of genes outside the subtelomeric regions or genes
related to antigenic diversity and immune evasion. Many of these genes are of unknown
function and may represent unrecognized genes encoding extracelluarly exposed proteins.
Duplication  of  biochemical  and  cellular  process  genes  appears  minimal  nor  does
evidence of non-functional duplication. Given active duplication elsewhere and evidence
that  drug resistance  can  form through duplication,  this  suggests  that  duplications  are
poorly  tolerated  within  the  genome  and  rapidly  lost  compared  to  organisms  where
genomic duplications can be maintained despite loss of function.  The few duplications
that  do  occur  unrelated  to  cytoadherence  and  extracellular  exposure  are  limited  to
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intrachromosomal tandem duplications, whether singly genic or non-genic tandem repeat
elements. The rRNA related genes benefit from duplication because of increased gene
dosage and life cycle specific expression and function. The SERA family of genes, where
the individual genes have evolved specialized function during various life stages, have
expanded for diversification of function. The identification of the duplication of these
genes can aid in understanding the biochemical and functional roles these proteins have
and the selective pressures placed on them. However,  the staid nature of the genome
suggests that a duplication is likely of functional consequence – particularly for a recent
duplication that is still unfixed and copy number variant (CNV) within the population.
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3.1 Introduction
Copy  number  variation  represents  duplications  and  deletions  ranging  from
hundreds of bases to megabases in size that are unfixed in the population  [43]. Copy
number variation can be a means of rapid gene dosage adjustment for organisms and
novel gene genesis [4, 5]. In the human genome, copy number variants (CNVs) represent
a  significant  source  of  genomic  variation  resulting  in  wide  range  effects  underlying
normal phenotypes as well as disease  [128]. While the previous segmental duplication
analysis  often identifies  ancient  and fixed duplications,  copy number variation in  the
population of Plasmodium falciparum may represent the latest avenues of adaptation to
recent or current selective pressures. Aspects of parasite physiology impacted by copy
number  variation  can  include  parasite  growth  rate  modifications,  increased  antigenic
diversity,  and increased metabolic  rates  [25].  Significant  interest  in  the  field  of  copy
number variation in P. falciparum has been engendered by the discovery of multiple gene
amplifications directly related to drug resistance, particularly duplications of  mdr1  and
gch [50,  70].  In  addition  to  drug resistance,  copy number  variants  offer  avenues  for
changes to parasite fitness by adapting gene dosage to alter growth rate, differentiation
rate,  nutrient  metabolism,  etc.  These  changes  can  all  be  in  response  to  geographic
selective pressures,  whether  by human genetic  adaptation,  government  regulation and
protocol, changes in drug regime, or seasonal weather changes.
Copy number variation has yet to be fully explored in  P. falciparum despite its
known importance in drug resistance and antigen diversity  [129]. Since then, multiple
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studies have investigated the extent of copy number variation within the parasite genome.
The first  genome wide studies utilized array comparative genomic hybridization  [83].
The advent of next generations sequencing has rapidly decreased the cost, increased the
amount of data, and improved the ease of preparation for genome wide sequencing of P.
falciparum [88, 130]. There are now numerous methods for the analysis of copy number
variation leveraging whole genome sequencing [85, 86]. All employ combinations of read
depth, discordant read or read pair mapping to a reference genome or de novo assembly.
These methods are not always easily applied to P. falciparum given its low GC content
which can lead to extremely biased sequencing and read mapping  [119].  Given these
specific challenges, there has been additional effort to develop and tune algorithms to
detect  copy  number  specifically  in  P.  falciparum [84–86].  However,  to  date  these
methods have only been applied to laboratory strains and the true extent of copy number
variation is  unclear  due to the fact  that  (1)  there is  concern that  many copy number
variants may be driven by culture adaptation  [131] and (2) the copy number detection
often has had low specificity and so a relatively high false discovery rate. Given this, we
have implemented a computational methodology written in Python to utilize read depth to
identify copy number variation combined with confirmatory discordant  read pairs.  In
combination,  this  provides  reasonable  sensitivity  and specificity.  We then apply  it  to
publicly available Illumina libraries of natural isolates consisting of 33 unique isolates of
P. falciparum from three sites in Senegal over the time period of 2004-2009 [87].
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3.2 Methods
Data collection
DNA from in vitro cultures  of  3D7, FCB and 106/1 were sequenced by non-
amplified paired end Illumina GAII sequencing utilizing PCR free library construction
(SRA: PRJNA279397) [119]. We also used 33 publicly available paired end sequencing
libraries from Senegal demographics study by H. Chang et al. [87] Samples represented
isolates from three different villages - Pikine, Velingara and Thiès - between the years
2004-2009 with either GAII or HiSEQ2000 sequencing technology (sequence data can be
accessed at SRA: SRP018047).
Overview of CNV detection
We developed  a  custom suite  of  Python  and  Java  programs  to  identify  copy
number variants (Figure 3.1) and optimized it for use within the  P. falciparum genome
with the goal of having sensitivity and specificity down to the gene and exon level. The
methodology combined two well-described  metrics. First, initial regions were identified
based on either greater than or less than expected read depth after correction for GC-
biases  in  the  sequencing.  Second,  putative  regions  of  high  or  low  read  depth  were
confirmed based on the presence of discordant read pairs. Combining these two methods
in succession provided the improved specificity. Given the highly divergent nature of the
subtelomeric  regions  and  particularly  the  var  genes,  where  read  placement  on  the
reference genome often fails due to high levels of divergence, we excluded these regions
from our analysis.  Accurate delineation of copy number variants within these regions
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Figure 3.1 Overview of CNV detection pipeline. GC-biased read depth is normalized
on a per read basis. A mean shift algorithm is used to identify signals of variant read
depth by local mean minima and maxima. Mean shift identified variants in read depth are
verified by discordant reads near mean shift identified breakpoints (spanning reads for
deletions; inverted reads for duplications).
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will likely require better assembly techniques as well as longer reads. 
At the cores of our read depth analysis, we employed the mean shift algorithm
from CNVnator by Abyzov et al. [84] which we reimplemented and modified. As input
for sequencing depth, we also developed a per read pair read correction method to correct
GC biases in the next-generation sequencing at the level of the read pair.  Read-based
rather than window-based correction allowed us to more accurately compensate for the
sharp  transitions  in  GC  content  between  coding  and  non-coding  sequence  in  P.
falciparum. To normalize the depth by a per read basis, we assigned a normalized depth
value to individual reads based on that read product GC%, by a ratio of observed versus
expected reads at each 2% interval of GC%. Read pairs within an over-represented GC%
bin were  down-weighted,  while  under-represented  pairs  received  proportionally  more
weight. Modification involved reversing the order of bandwidth search -  large (512,000
bp) to small (400 bp) windows. An iterative t-test, with a p-value of 0.05, was used for
each test of bandwidth for potential read depth variants. After identification of variant
regions, we used a Bonferroni correction for all iterative tests for each bandwidth tests
during the mean shift segmentation. Regions passing cutoffs for copy number variation
were  than  examined  for  supporting  discordant  reads  indicative  of  true  copy  number
variants. A minimum of two discordant read pairs that correlated with the defined copy
number variant region were required – inverted reads for duplications (minimum distance
between pairs of 300 bp) and paired reads with insert lengths greater than 1000 bp for
deletions.  In  order  to  detect  copy  number  variants  that  might  transition  into  the
subtelomeric  regions,  we  included  detected  copy  number  variants  proximal  to  the
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subtelomeric regions – as defined by non-syntenic regions and var genes in the middle of
the chromosome – that passed a stricter threshold for deletions, i.e. a mean read depth
value of less than 0.05.
GC normalization of read depth
We  aligned  paired  end  read  libraries  with  Bowtie  2  using  default  alignment
settings [120]. Sequence alignment/map (SAM) files from Bowtie 2 were converted to a
binary  sequence  alignment/map  (BAM)  file  and  sorted  by  coordinate  with  samtools
[121]. To determine the expected values for read depth on GC bias, we determined the
GC% for all possible read products (i.e. the sequence fragment) from 50 bp to 1,000 bp
and their  frequency within the genome. We notated the number of read products (by
product size and then GC%), simulating an expected rate of read product GC% and size. 
We input coordinate sorted BAM files into a custom python program to determine
the normalization factor to apply to each read. Aligned reads were assigned to deciles of
product size. Expected read product sizes and their GC% counts were similarly assigned
to the same deciles. Within deciles of read product size, we counted reads by GC% for
every 2% GC window for both expected and observed read products. For every 2% GC
window at each product size decile, we normalized the read product counts by the total
number of read products at that product size decile. This was performed on both observed
and expected read counts. We calculated the correction factor for reads at each 2% GC
window within its product size decile as the normalized expected count divided by the
normalized observed count.
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Based on this, we assigned each read the appropriate correction factor for its read
product  GC%  and  read  product  size.  Given  these  corrected  reads,  we  summed  the
correction factors of all reads aligned to a given loci for all base pair positions in the
genome (the pileup file).
Mean shift analysis of normalized read depth
We ran GC bias corrected read depth pileup file through a modified mean shift
algorithm based. By chromosome, we iterated over the entire genome from bandwidths
512,000 bp to 400 bp, halving bandwidth per iteration. We then iterate over the new array
of  mean  read  depth,  given  current  bandwidth,  until  finding  a  segment  that  passes
minimum requirement  change  in  the  read  depth  of  the  mean  relative  to  the  overall
average (≤0.4 read depth or ≥1.4 read depth). Regions with local significant by t-test (p-
value = 0.05) given the variance of the read depth across the chromosome are kept. After
determining  mean  shifts  across  the  genome,  p-values  were  subjected  to  Bonferroni
correction given all possible bandwidths across the chromosome. Segments meeting all
statistical criteria representing putative copy number variant regions were outputted to a
browser extensible data (BED) file.
Discordant read pair intersection analysis and breakpoint trimming
We searched through the coordinate sorted BAM file for discordant reads. We
denoted read pairs with a product size greater than 400 bp into a bed file to compare
mean shift identified deletions (Figure 3.1). We also denoted everted read pairs of product
size greater than 300 bp to compare mean shift consistent identified duplications (Figure
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3.1). We then intersected the mean shift identified copy number variation calls with the
discordant reads. For valid intersection, we required all read placements to be within a
specified  distance  from either  side  of  the  estimated  boundaries  –  20% of  total  copy
number variation  size for  all  variants  less  than  2,000 bp and 100 bp for  all  variants
greater than or equal to 2,000 bp. We then required every mean shift  identified copy
number variation calls to have a minimum of two discordant reads pairs – everted reads
for duplications and spanning reads for deletions – to validly intersect.
To refine the breakpoints for copy number variant regions, we used the innermost
reads from discordant pairs as inference of the maximal true breakpoint. We adjusted the
estimated copy number variation breakpoint to be within 50 bp of the minimum and
maximum positions of all intersected discordant reads for that copy number variation,
which essentially defines the maximal size of the breakpoint of the copy number variant
region.
3.3 Results
Copy number detection within well-characterized laboratory strains
Initial  mean  shift  identification  of  3D7,  at  the  p-value  of  0.05  (subsequently
adjusted by Bonferroni correction) for testing for variance within mean shift bandwidths,
resulted  in  the  identification  of  one  copy  number  variant  region  compared  to  the
reference genome: gch (PF3D7_1224000). The mean shift identified duplicated region of
gch coincided with two pairs of inverted reads. This singular genic copy number variation
is  a  known duplication  in  the  3D7 strain  of  P.  falciparum from which  the  reference
63
genome is based, but was not assembled [132]. From further testing of the mean shift
copy number variation identification on both the FCB and 106/1 laboratory strains, we
identified from the mean shift on read depth 108 copy number variants outside the sub-
telomeric regions at a testing threshold bandwidth p-value < 0.05 and segment size  ≥
400bp. As these were well-characterized laboratory strains, the 108 identified mean shift
variants represented numerous false positives. With more stringent p-value thresholds, the
number  of  identified  copy  number  variants  significantly  decreased.  When  taken
separately, the discordant read analysis displayed lower specificity, identifying over 2,000
regions with discordant read pairs per library. Additionally, there was great variability
between library preparations for both GC bias (Figure 3.2) and the number of mean shift
calls (Figure 3.3). The high rate of false positives with either method alone suggested the
need to combine these metrics to improve specificity. The best combination was simply
to use the discordant read placements as confirmation of read depth based CNV calls.
Doing this,  we identified only 11 copy number variants in  the 3D7, FCB, and 106/1
strains –  representing 5 copy number variation regions (Table 3.1).
Four of the five copy number variant regions had been established in laboratory
strains and were genic. There were no known CNVs within these strains that were not
detected suggesting the algorithm has good sensitivity to detect typical genic CNVs. We
determined  that  3  instances  of  genic  copy number  duplications  were  related  to  drug
resistant alleles – gch, mdr1, dhfr. The duplications had significant support from inverted
read pairs (Figure 3.4). These genes have been well documented as copy number variant
[87]. The two deleted regions on chromosome 9 for both FCB and 106/1 are known
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Figure 3.2 High variability of GC bias between sequencing libraries. Histograms of
GC% between sequencing library  replicates  display  the  extent  of  variability  between
sequencing library preparations. Orange and blue lines represent two technical replicates
of Illumina GAII sequencing libraries from a in vitro 3D7 lab culture DNA isolate.
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Figure 3.3 High variability read depth based mean shift CNV identification between
sequencing libraries. We detected orders of magnitude difference in the CNV calls by
our read depth mean shift method in three in vitro cultured laboratory strains: 3D7, 106/1,
and FCB. While more stringent p-values reduced the number of false positive CNV calls,
FCB and 106/1 still maintained high numbers of false positive CNV calls.
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Table 3.1 Identified CNV from  in vitro cultured lab strains. We identified 5 CNVs
from in vitro cultured lab strains 3D7, 106/1, and FCB. Two were well-studied CNVs of
drug resistance associated alleles:  gch and  mdr1. We also identified another novel drug
resistance associated CNV in dhfr. In addition, the chromosome 9 CNV is well-known as
an in vitro culture adaptation.
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Strain Chrom Position Length
106/1 4 732101 - 783400 51299 pfdhfr1 1.91
FCB 5 868901 - 964600 95699 pfmdr1 2.09
106/1 5 869001 - 952700 83699 pfmdr1 1.65
FCB 7 1293001 - 1295500 2499 - 0
106/1 9 1374001 - 1396100 22099 pfgdv1 0
FCB 9 1374401 - 1396000 21599 pfgdv1 0
FCB 9 1459502 – 1541735 82233 - 0
106/1 9 1459502 – 1541735 82233 - 0
106/1 12 946301 - 980600 34299 pfgch1 4.24
FCB 12 961501 - 980600 19099 pfgch1 2.90
3D7 12 974301 - 975900 1599 pfgch1 3.67
Presumed 
relevant 
gene
Copy 
Number
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Figure  3.4  Intersection  of  read  depth  and  discordant  reads  identifies  CNV  of
PFE1150w  and  PFI1710w. A)  Read  depth  of  the  FCB  copy  number  variation  on
chromosome 5 over the PFE1150w (mdr) locus was verified with the presence of 20
inverted reads. Above, the read depth is displayed centered around a normalized read
depth for both 3D7 and FCB. Below are the alignment of inverted read pairs that overlap
the duplicated region. B) Read depth of the FCB copy number variation on chromosome
9 of the PFI1710w (gdv) locus was verified with the presence of spanning reads. Above,
the read depth is displayed centered around a normalized read depth for both 3D7 and
FCB. Below are the alignment of appropriate orientation read pairs with a read product
length greater than 400 bp.
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deletions that are common occurrences within in vitro cultured strains [84]. This deletion
has been shown to be stable in two isoforms as either a single large deletion or a two part
deletion with a single genic deletion of gdv (PFI1710w) and the rest of the subtelomeric
region after some variable amount of intervening sequence – of which both 106/1 and
FCB were the latter  (Figure 3.4)  [71,  133].  Our read depth based copy number calls
accurately estimated the copy number of duplications. We compared of our read depth
copy number estimations against our own qPCR results and those in the literature (Figure
3.5)  [71].  We found  that  our  estimated  copy  number  calls  for  read  depth  correlated
strongly with the qPCR results (R2 = 0.902).
Copy number detection within Senegal strains
To examine the extent of copy number variation in a natural popuation, 33 paired
end P. falciparum samples from Senegal were analyzed for copy number variation with
our  computation  methodology.  Ignoring  copy  number  variants  located  within  the
subtelomeric regions or internal  var clusters where reads poorly map to the reference
genome,  we identified 1445 potential  copy number variant  calls  from the read depth
based mean shift at a testing threshold with a p-value of 0.05. A small random sample of
potential copy number variation targets outside the subtelomeric regions were queried by
qPCR, but were proven to be false positive (data not shown) confirming a high false
positive rate in a purely read depth based method. Inspection of the read depth at these
copy  number  variation  regions  indicated  the  potential  for  regional  biases  between
libraries. This further highlighted the need for a secondary metric as unaccounted for
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Figure 3.5 Accurate estimation of copy number via read depth based CNV detection.
We compared our copy number estimates for duplications to qPCR results from both our
lab and the literature (R2 = 0.902). Denoted points were qPCR results from: *Kidgel et
al., 2006 [132]; ** Kiwuwa et al., 2012 [134].
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biases apart from read depth cause library variability. After filtering for the mean shift
calls with discordant read pairings, eight copy number variant regions were discovered
across the isolates in non-subtelomeric regions. Only two of the copy number variants
were duplications, and six of the eight involved at least partial genic content (Appendix
Table 1). Only one of the duplicated copy number variants were genic.
Five of  the  copy number  variants  were  recurrent,  with four  of  the five being
deletions and three of the five having genic content. The chromosome 2 and 9 deletions
of the telomeric arms are known adaptations to in vitro cultures. Considering this, these
copy number variants, along with the telomeric arm deletion copy number variation on
chromosome  1,  may  be  predominantly  a  result  of  the  short  term  in  vitro culture
adaptation prior to library preparation. All three were recurrent deletions.
Antigenic genes were the largest contributor in the genic copy number variants.
Excluding the three copy number variants suspected of in vitro culture adaptation, we
identified a total of 20 genes in all other copy number variants. Nine of these genes had
unknown  function.  Another  nine  were  antigen  associated,  with  six  being  merozoite
protein  in  the  chromosome  10  copy  number  variation.  Additionally,  there  was  little
evidence for any bias in GC% for copy number variants. The mean GC% for the copy
number variants was 20.0%, whereas the genomic mean is 19.34% GC  [71]. Only the
non-genic duplication on chromosome six had a significant difference in GC% at 10%
GC. However, the copy number variants showed a small but statistically significant bias
(two-sided t-test, p-value = 8.3x10-3) for increased tandem repeat content, with the mean
tandem repeat content of the copy number variants being 25.02% of the copy number
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variation as opposed to the total tandem repeat content of the genome at 14.93%. This
implies that significant tandem repeat content is not a factor in creating copy number
variants.
3.4 Discussion
We  created  an  improved  computational  method  for  identifying  copy  number
variation from next gen sequencing technology that combined both a read depth based
metric  and a  discordant  read pair  metric.  A single metric  alone fails  given the high-
sensitivity  needed  within  a  genome  with  a  paucity  of  copy  number.  Testing  it  on
laboratory strains with known copy number variants, we were able to accurately identify
those known copy number variations. The read depth of the natural strains of 33 paired
end  sequenced  P.  falciparum strains  from  Senegal  showed  systemic,  variable,  and
regional  biases,  resulting  in  false  positive  copy  number  variation.  Our  process  of
improved  mean  shift  depth  analysis  combined  with  discordant  read  pairs,  greatly
improved specificity,  removing many of  these false  positives.  Overall,  we discovered
significant evidence for only 26 copy number variants, of which only nine were genic,
suggesting natural populations of  P. falciparum are relatively conserved, excusing the
subtelomeric regions.
The systemic biases discovered in the Senegalese samples show that a purely read
depth based approach to copy number variation discovery may be highly fraught with
false positives. These biases also showed little relation to the overall variability of read
depth in the sample. As we did not see the phenomenon in the in vitro lab samples, there
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is some variable between source DNA quality, library preparation or sequencing that can
cause these systemic biases. Guarding against such biases will be important for all future
investigations. Using a secondary metric independent of read depth effectively mitigated
the effect of the systemic bias dramatically increasing our specificity. This alleviates the
need to investigate the cause for the systemic bias and further normalization of the data.
Our method can be applied to current sequencing efforts without additional sequencing or
laboratory testing.
Our analysis of the Senegal population of P. falciparum indicates a very quiescent
population, as concerns copy number variation. Discounting the large chromosomal arm
deletions, there were only three copy number variants with genic content. Of those genes
affected, antigenic genes were the common element. We found no amplification of genes
with potential known effects on drug resistance. While gene amplifications for known
drug resistance  alleles  have  been shown to  be  uncommon,  the  relative  lack  of  copy
number variation is unsurprising  [132, 134]. This may be a regional effect due to sudden
bottlenecking or from a vast effective population – to the random exclusion or dilution of
copy number variation propagation respectively. The majority of samples sequenced and
analyzed  for  copy  number  variation  analysis  were  from 2008-2010,  after  significant
inroads  were  made  by  Senegalese  government  for  malaria  control  –  reporting  an
estimated 41% drop in confirmed malaria cases between 2008 and 2009 [33]. R. Daniels
et al. (2013) further supports this idea from their determination that over this time frame
there  had  been  a  significant  increase  in  propagation  of  clonal  populations  of  P.
falciparum in Senegal [135], which was shown to not be occurring in neighboring regions
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[136]. This evidence points to a limited pool of genetic diversity of  P. falciparum in
Senegal. Alternatively, the changing landscape of drug use in the region may be at cause
for the lack of copy number variation variety.
In  addition,  recent  drug  efforts  within  Senegal  may  have  produced  differing
selective pressures on copy number variation propagation, as they have with particular
resistance associated allele frequencies [137]. Without analysis of other populations of P.
falciparum, we cannot be certain that relative paucity of copy number variation results
are not a peculiarity of this population or if it is truly indicative of extent of variation
throughout  the  global  P.  falciparum population.  However,  our  analysis  of  a  few
laboratory strains suggests that it is most likely a global phenomenon, consistent with our
duplication analysis and comparative analyses, that central regions of the chromosome
are very staid. With our methods for highly specific copy number variation identification
from next gen sequencing technology, an investigation of the global population of  P.
falciparum for copy number variation is the next logical step.
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CHAPTER IV: Global Analysis of Copy
Number Variation in P. falciparum
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4.1 Introduction
Little is known of the extent of copy number variation in Plasmodium falciparum.
Many studies have investigated the impact and significance of previously identified copy
number variants. These copy number variants were identified via qPCR and genetic cross
screens for identification of drug resistance factors  [91].  These specific copy number
variants were further investigated to determine the various isoforms and copy number of
copy number variants within populations of P. falciparum [136–138]. Until recently, the
study of copy number variation has been performed after determination of its role in drug
resistance. However, a few studies have attempted to capture genome-wide copy number
variants  by array CGH or  through next  gen sequencing  [69,  81,  82].  Most  work has
focused on lab strains and little has been done to gain a comprehensive study of copy
number variation globally.
The investigation of copy number variants in P. falciparum to date has not been
sufficient to understanding either the extent of coverage or the extent of its effects. Lab
strains are not representative of the P. falciparum population as a whole. In particular, the
bias for study of drug resistance, both in strains and copy number variants, ignores large
regions of the potential adaptive benefit of copy number variants for the parasites. A more
comprehensive study of copy number variants in a natural population can identify gene
targets under selective pressure other than drug resistance, such as adaptations to human
immune pressure or external factors like bed netting and insect repellent. In addition, in
vitro culture  introduces  its  own  biases  for  adaptation,  as  evidenced  by  recurrent
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independent deletions of large regions of the genome in lab strains  [70, 80]. Therefore,
we  have  potentially  only  studied  a  microcosm  of  the  copy  number  variation  in  P.
falciparum.
Our  previous  work  has  been  shown to  rapidly  and  specifically  identify  copy
number  variants,  both  in  vitro and  in  a  natural  population.  The  nature  of  next  gen
sequencing  provides  a  rapid  and  cost-effective  means  to  broadly  identify  genomic
variation, i.e. sing nucleotide polymorphism, structural variation, and now copy number
variation [83–86]. The natural progression would be to extend our technology to a global
data set. Large scale sequencing studies of  P. falciparum are becoming common and a
wealth of sequencing data is accumulating around the globe. We use our methodology for
copy number variation detection from high throughput sequencing to investigate copy
number variants across these publicly available sequencing datasets from a large global
sample of P. falciparum.
4.2 Methods
Sample acquisition and quality control
The  set  of  whole  genome  shotgun  sequences  of  P.  falciparum isolates  was
gathered from multiple published papers and publicly available sequence data: Burkina
Faso, Gambia, Ghana, Mali, Cambodia, Thailand [71]; Guinea [44]; Gambia [88]; Kenya
[139]; Senegal [90] (Figure 4.1). All samples had been pair end Illumina sequenced. We
merged  samples  with  multiple  sequencing  libraries  prior  to  normalization.  We  had
previously  determined  that  of  the  samples  with  multiple  libraries  there  was  minimal
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Figure 4.1 Map of P. falciparum sample origin.
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difference in read depth variation between GC normalization on individual libraries and
merged  libraries.  We  filtered  any  sequencing  libraries  with  less  than  70%  genomic
coverage or less than 10x coverage, as both criteria are required for initial read depth
analysis. We tested the remaining sequencing libraries for multiplicity of infection with
estMOI  [89].  No sampled showed greater  than  a  cumulative  5% secondary  infection
insuring  that  multiple  strain  infections  would  not  confound  our  analysis.  The  final
cleaned data set had 610 unique samples. From this, we can refer to each sample as being
a unique strain as concerns copy number variation and major allele identification.
Copy number variation identification
We analyzed all  sequencing libraries  for  copy number  variation  as  previously
established. We normalized read depth for GC bias on a per read basis. Then we analyzed
the normalized read depth for copy number variation with a mean shift algorithm. We
removed any copy number calls  that intersected with the subtelomeric regions or var
clusters  due  to  an  inability  to  adequately  account  for  significant  sequence  diversity
between paralogs. These regions were effectively removed with the secondary metric of
read  discordant  reads:  inverted  read  pairs  for  duplications  and  spanning  reads  for
deletions.
Principal component analysis for CNV subgroup analysis
To look for population structure associated with particular CNVs, we partitioned
the isolates to those having or lacking a particular copy number variant and assessed the
SNPs by principal  components.  Specficially,  we examined all  SNPs  from PlasmoDB
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version 9.3. SNPs were called by GATK version 2.8.1 with local indel realignment and
verified against the PlasmoDB SNP database  [140]. For each chromosome, an array of
GATK-called SNPs limited to the sites in PlasmoDB version 9.3 per sample was built for
principal component analysis in R with prcomp. Analyzed samples included only regions
positive for the copy number variants:  Cambodia for plasmepsin duplication; Burkina
Faso, Ghana and Guinea for crt duplication; Thailand and Cambodia for both mdr1 and
gch duplications.
4.3 Results
Identified copy number variants
From 610 samples, we identified 68 copy number variant regions – 54 of which
were duplications and 61 of which were genic (Appendix Table 1). We determined that 61
of the copy number variants intersected a gene, however only 33 fully encompassed a
gene (for at least one isoform). In addition, we determined that 22 of the 68 copy number
variants were recurrent between strains. Within these 22 copy number variants, 16 fully
encompassed a  gene.  When considering the individual  copy number variants  in  each
strain,  only  17  instances  of  unique  genic  copy  number  variants  were  present.
Alternatively,  the  recurrent  deletions  accounted  for  144 individual  instances  of  genic
copy number variants.  Of the 22 recurrent copy number variants,  we determined that
copy number variants were not necessarily confined to a particular country or region.
Nearly half of the recurrent copy number variants were restricted to a single region (West
Africa, East Africa, South East Asia) with 10 of the 22 recurrent deletions spread between
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multiple regions. It was even rarer to find a recurrent copy number variant confined to a
single country, with only 6 copy number variants remaining confined to a single location.
However,  copy  number  variants  between  continents  were  more  limited.  This  may
highlight differences in selective pressures between continents.
The frequency of strains with genic copy number variants was highly variable
both between copy number variants and geographic regions, ranging from 2% to 54%
(Figure 4.2). Strains averaged 0.50 copy number variants, with a range between 0 and 5
copies per strain and a standard deviation of 0.82. However, Cambodia and Thailand both
had significant percentages of their population with genic copy number variants, with
40% and 55% respectively. African samples had a much lower frequency of copy number
variation.  All  African  samples  were  under  10%  frequency,  except  Ghana  at  16%.
However, the high frequency of copy number variants in South East Asia is mostly due to
two recurrent copy number variants of mdr1 and gch. In Cambodia, 42 out of 62 strains
with copy number variants were due to  mdr1 or  gch,  while Thailand had all  samples
containing  a  copy  number  variant  with  either  a  mdr1 or  gch duplication.  The  gch
duplication accounted for 6 of the 12 strains in Ghana with copy number variants.
Across  the  genome,  copy  number  variants  showed  no  bias  for  particular
chromosomes, nor any pattern to location of the copy number variation (Figure 4.3). We
found that the copy number variants also did not show biases toward GC%, with a mean
of 18.8% GC in all copy number variants as compared to the genomic mean of 19.4%.
While  we noticed an increase in  tandem repeat  content of the copy number variants,
however the difference in mean tandem repeat content of 18.4% for copy number variants
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Figure 4.2 Frequency plot of genic CNVs. The frequency plot of genic CNVs indicates
that  most  genic  CNVs  are  present  at  a  low  level  in  the  population.  However,  we
discovered  a  number  of  genic  CNVs  that  are  highly  prevalent  in  the  population  –
particularly gch and mdr1 duplications.
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Figure  4.3 Overview of CNV loci throughout the genome. The distribution of CNV
loci indicates that there is likely no bias for particular regions or loci in the genome (not
considering the subtelomeres).
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against the genomic mean of 14.9% was not statistically significant (double sided t-test,
p-value = 0.081).  We determined that  there were likely no biases between GC% and
tandem repeat content related to copy number variation size as there was little difference
between  the  unweighted  means  and  the  copy  number  variation  size  weighted  means
(weighted GC% mean = 20.1%, weighted tandem repeat percentage = 19.5%).
The  distribution  of  copy  number  from  the  various  isoforms  of  all  detected
duplications indicated that most have a copy number of between 2 to 3, with the number
of  duplications  with  high  copy  number  rapidly  dropping  past  3  copies  (Figure  4.4).
However, the copy number did reach as high as 14 for gch. The recurrence frequency of
copy number variants indicated that the majority recurred between less than five strains.
However, the range of frequency was wide, ranging up to 73 strains for a deletion and 28
strains for a duplication (Figure 4.2).
Copy number variation size was skewed toward smaller sizes (Figure 4.5). The
majority of copy number variants were under 30 kbp, and the vast majority under 60 kbp.
The small selection of copy number variants greater than 60 kbp were all large deletions
of the subtelomeric arms of chromosomes. These deletions are considered in vitro culture
adaptations, so  in vivo there is strong pressure to limit large copy number variants  [71,
133].
Genes within copy number variants
We discovered 201 genes full encapsulated within a copy number variant regions,
of  which  79  (39%)  were  of  unknown  function.  Between  recurrent  and  single  copy
number variants, the majority of genic copy number variants were recurrent, with 132
92
Figure  4.4  Copy  number  of  genic  duplications  indicate  preference  for  minimal
duplication. The frequency of higher copy numbers drops drastically after 4 copies, with
most duplications found at two copies. However, there are a few high copy duplications,
with a notable example being gch at 11 copies.
93
94
Figure  4.5 Majority of CNVs are under 40 kbp. The histogram of genic CNV size
indicates that most CNVs prefer smaller sizes – under 40 kbp. There are few CNVs larger
than 60 kbp, and those are deletions of entire subtelomeres of chromosomes.
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genes  in  duplications  (from  16  CNVs)  and  69  genes  in  deletions  (from  6  CNVs).
Alternatively, 122 genes were found in single strain duplications (from 39 CNVs) and
only 13 genes in single strain deletions (from 6 CNVs). However, of those 6 recurrent
deletions, 3 were previously identified as copy number variants in the Senegal strains that
are potentially in vitro culture adaptations – the loss of chromosome 9 subtelomere, the
loss  of  chromosome  2  subtelomere,  and  potentially  the  loss  of  chromosome  1
subtelomere. These are deletion events that have not been seen directly  in vivo, but are
frequently  produced  over  long  term in  vitro culture  of  an  isolate  [71,  133].  These
deletions often result in loss of gametocytogenesis, loss of cytoadherence, and increased
growth rate in vitro [71, 131, 141, 142].
We found multiple recurrences of two well-known and characterized copy number
variants of mdr1 and gch. Overlay of the copy number variants of mdr1 and gch (Figure
4.6 and 4.7) compare similarly to previous studies on break points and copy number of
those specific genes in a natural population of P. falciparum [87]. We identified the mdr1
gene solely in South East Asia, however the gch duplication was identified in Ghana in
addition to South East Asia. Both copy number variants had a high frequency, with the
mdr1 duplication found in 32 strains and the  gch duplication recurring in  57 strains.
Without  information  on the  sampling  protocols  or  timeline  of  sample  collection,  we
cannot ascertain whether the disparity in geographic location of the two copy number
variants was due to a bias in sample collection timing between studies or an effect of
differing  drug regimes  between  regions.  Previous  studies  have  shown that  the  mdr1
duplication exists at a low frequency in West Africa [143].
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Figure  4.6  Multiple  isoforms  of  mdr1 duplication  identified. We  conservatively
identified 5 separate isoforms of the mdr1 duplication by breakpoint, with each isoform
having variable copy number. Copy number ranged from 2-3 copies.
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Figure  4.7  Multiple  isoforms  of  gch duplication  identified. We  conservatively
identified 6 separate isoforms of the  gch duplication by breakpoint, with each isoform
having variable copy number. The copy number ranged from 2-11 copies.
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In addition, we discovered many novel copy number variants. Of particular note
was the novel copy number variation of another drug resistance associated allele –  crt
(Figure 4.8). This copy number variation was identified in West Africa, spanning multiple
countries. The crt copy number variation was a duplication with a copy number of two
and identified six times between Burkina Faso, Ghana, and Guinea.
Of the 201 genes identified to be copy number variant, 79 had unknown function.
Gene ontological testing of the other 122 identified genes with GOstat found no over- or
underrepresentation  of  gene  ontology  terms  [123].  Between  different  isoforms  of  a
recurrent copy number variation, a set of intersecting genes could potentially highlight
the gene under selection in the copy number variation. While this reduced set did not
elucidate the causative allele under selection for all copy number variants, a literature
search of potential targets informed us of possible hypotheses for select copy number
variants. Duplication of plasmepsins II and III (PF3D7_1408100 and PF3D7_1408000)
on chromosome 14 was present in 17 strains, all in Cambodia. These plasmepsins form a
complex that is involved in the hemoglobin-to-hemozoin process in the parasite's food
vacuole  [144,  145].  Chloroquine's  mechanism  of  action  is  via  interruption  of  the
hemoglobin-to-hemozoin process to allow free heme to form, which is highly toxic for
the parasite  [146, 147]. The duplication of topoisomerase I (PF3D7_0510500) also had
implications with chloroquine resistance in the literature.  Chloroquine has been shown to
be a catalytic inhibitor of human topoisomerase I  [148].  While topoisomerase I  in  P.
falciparum has significant sequence divergence from human topoisomerase I, there is still
the  potential  for  similar  chloroquine  interaction  considering  there  is  likely  high
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Figure  4.8 Identification of single isoform of  crt duplication. We identified a novel
CNV of the crt gene. Only one isoform was discovered, all at a copy number of 2.
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conservation of the catalytic site. However, most genes involved in copy number variants
had little literature on their importance or the functional implications of copy number
variation.
Biallelic crt duplication
Upon closer inspection of the crt duplication, we discovered that the duplication
was biallelic in that we identified both the chloroquine sensitive and chloroquine resistant
alleles in the duplication (Figure 4.9). This phenomenon was not seen in any other copy
number  variation.  We  found  that  all  SNPs  within  the  copy  number  variation  of  crt
approached 50% frequency in the read depth. From paired read linkage, we could verify
that  neighboring  SNPs  were  in  linkage  within  individual  copies  of  crt.  This  lends
credence to the idea that two separate alleles were present in the copy number variation. 
SNP analysis identified nine non-synonymous mutations in exonic regions of crt.
Included in the mutations is the K76T mutation considered a cornerstone for chloroquine
resistance [70, 80]. However the K76T mutation alone is insufficient  [149]. In total, all
the identified biallelic SNPs in the crt duplication correspond to SNPs in the crt allele in
the chloroquine resistant lab strain Dd2, except for one position at 405,600 bp that did not
have a Dd2 linked SNP or were the chloroquine sensitive wild type allele [150, 151].
We determined that recombination had occurred within the copy number variation
itself, creating divergence between strains sharing the copy number variation. Breakpoint
analysis  of  the  crt copy  number  variation  with  Pindel  (version  0.2.5)  found  exact
breakpoints of 398,871 to 421,765 bp on chromosome 7 in sample 43 from Burkina Faso
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Figure 4.9 Biallelic duplication of crt gene. We discovered that SNPs within the the crt
gene were biallelic, with the alternative allele ranging from 30-70% of the read depth.
SNPs corresponded with a chloroquine sensitive allele and a chloroquine resistant allele.
Aligned reads are visualized along  crt, with non-reference bases highlighted along the
gene. Zooming in on a particular SNP loci displays identification of biallelic SNPs.
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[152, 153]. These Pindel defined breakpoints correlated well  with our mean shift and
discordant read identified maximal-span breakpoints of 398,679 to 421,905. Both Pindel
identified  breakpoints  located  to  a  long  poly-A stretch  (>10 bp).  We analyzed  SNPs
within the copy number variation and flanking regions to identify divergence between the
six  recurrences  of  the  copy  number  variation  (Figure  4.10).  We  determined  that  the
shared  haplotype  diverges  upstream at  378,904  bp  –  about  20  kbp  upstream of  the
breakpoint.  However,  the  shared  haplotype  ends 3'  within the  copy number variation
itself at 414,615 bp.
Principal component analysis of SNPs located on chromosome 7 for strains in
Burkina Faso, Ghana, and Guinea indicated that there was no subgrouping of strains with
the crt duplication (Figure 4.11), consistent with their observance in multiple countries.
Principal  components  1  and 2  were  still  affected  by  geographic  effects.  However,  at
principal components 3 and 4, where geography had much less impact, variation within
the  crt duplicated strains was in line with the rest of the West African population. The
lack of a separate subgroup of crt duplicated strains reinforces the identification of only a
~40 kbp region of non-divergence around the copy number variant. We can conclude that
the duplication has been in the population for some time, and has undergone significant
recombination around the locus, occurring over time as this duplication spread within
West Africa.
4.4 Discussion
This study is the first comprehensive analysis of copy number variation across the
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Figure  4.10  Consensus  sequence  diverges  within  the  crt CNV. By  tracking  the
consensus SNP around the crt locus, we determined the boundary of divergence between
the isolates' CNVs. The breakpoints of the crt CNV are 398,679 bp and 421,905 bp. The
divergence boundaries were at 386,728 bp and 414,614 bp.
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Figure 4.11 PCA of SNPs across chromosome 7 between geographic regions with crt
duplication. Plots of principal components identify significant effect from geographic
distribution on SNPs for chromosome 7. crt duplication positive strains are shown to be
not unique enough a subpopulation to separate, indicating significant recombination has
occurred around the duplication.
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global  population  of  P.  falciparum.  We have established a  baseline  for  copy number
variation in the core genome as compared to the 3D7 reference genome. Our analysis
indicates minimal copy number variation in the non-subtelomeric regions of the genome.
We found that copy number variation is a rare occurrence in  P. falciparum. Individual
strains averaged 0.5 copy number variants. However, the dearth of copy number variation
was most pronounced in Africa. Strains from South East Asia have a high rate of copy
number variation, with up to 50% of strains being positive for a copy number variation.
The contributing factor to this was the high frequency of either gch or mdr1 duplications.
Outside of those two copy number variants, South East Asia had similar rates of copy
number variation as Africa. From this, we can conclude that copy number variation in the
non-subtelomeric regions of the genome is rare, unless strong selective pressures elevate
the frequency of the copy number variant in the population. In this case, significant drug
pressure may be increasing the frequency of copy number variation in South East Asia.
From  our  analysis,  we  identified  numerous  novel  copy  number  variants.  By
literature  research,  a  number  of  these  copy  number  variant  genes  are  impacted  by
chloroquine in some manner – topoisomerase I and the plasmepsins being among those
genes. In addition, we identified a novel copy number variant of  crt, which has known
function regarding chloroquine resistance. We discovered a single isoform of the crt copy
number  variant  present  in  six  strains  between  Burkina  Faso,  Guinea  and  Ghana.
Additionally,  we  determined  that  the  duplication  was  biallelic,  containing  both
chloroquine resistant and chloroquine sensitive alleles. This potentially has significant
importance in future drug design and discovery. Strategies for combination therapy of
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drugs  that  target  both  chloroquine  resistant  alleles  and  chloroquine  sensitive  alleles,
taking  advantage  of  the  functional  constraint  on  crt mutations,  could  be  seriously
compromised  by  this  biallelic  copy  number  variation.  The  biallelic  duplication  also
potentially provides an adaptation to the fitness disadvantage that chloroquine resistance
typically  confers  in  the  absence  of  drug  [154,  155].  This  might  have  effects  on  the
improved retention of chloroquine resistance  or resistance to other antimalarials in the
population by reducing the disadvantageous effects of the chloroquine resistant allele.
From bacteria  to  fruit  flies  and humans,  P. falciparum has  comparatively low
frequency  of  copy  number  variation  [5].  Given  the  low  frequency  of  copy  number
variation in P. falciparum, it stands to reason that there is significant purifying selection
against the retention of copy number variation into the genome. The only cases of high
frequency  genic  copy  number  variants  in  the  population  are  due  to  drug  resistance-
associated alleles, such as mdr1 and gch. Given this, the observed existing copy number
variants likely confer some functional benefit providing an adaptive benefit. Our study
has  provided multiple  novel  targets  to  investigate  for  the functional  consequences  of
these duplications. As drug resistance played a prominent role in a number of identified
copy  number  variants,  study  into  these  other  copy  number  variants  may  provide
additional avenues for the evolution of drug resistance.
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CHAPTER V: Discussion
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5.1 Systematic analysis of duplications and deletions in P. falciparum
Duplications and deletions are an important avenue of adaptation and evolution.
They are a significant route for the diversification of genes, creation of new genes, and
the regulation of gene dosage. In  P. falciparum, these avenues are extensively used for
adaptation. Large gene families of genes encoding  extracellularly exposed proteins have
undergone significant duplication and divergence to improve amino acid diversity for
immune evasion. In addition, copy number variation (duplication) of the particular drug
resistance-related genes has provided increased expression and resultant increased drug
resistance in P. falciparum.
In our studies, we have attempted to systematically identify and analyze these
duplication and deletions in the genome. From our analysis of segmental duplications, we
have observed the compartmentalization of the genome with respect to the presence of
duplication. We determined the rarity of duplications in the core of the genome, where
few genes showed evidence of past  duplication.  From this,  we can infer that there is
strong selective pressure to conserve the core genomic genes and function leading to
removal  of  duplications  barring  strong  selective  advantage.  However,  we  identified
significant duplication of genes in the subtelomeres. The majority of genes duplicated
were genes under strong selective pressure for human immune evasion. This fits with the
inference that the parasite uses the subtelomeres to duplicate and recombine its repertoire
of extracellularly exposed genes,  thereby diversifying these genes for human immune
evasion.
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To  rapidly  and  specifically  identify  these  variable  duplications  and  deletions
between strains from high throughput sequencing data, we created a novel computational
method to identify copy number variants in the non-subtelomeric regions of the genome
from high throughput sequencing. This method increased the specificity of copy number
variation identification from high throughput sequencing libraries of clinical isolates. The
method involved GC bias normalization of read depth followed by detection combining
mean shift detection of regions and validation of these identified copy number variants by
discordant read pairs in the sequencing library. We applied this computational method to
publicly  available  high  throughput  sequencing  libraries  of  610 clinical  isolates  of  P.
falciparum from Africa  and  South  East  Asia.  We observed  a  rarity  of  copy  number
variation, with only high frequency for copy number variants correlating to known drug
resistance. Additionally, these high frequency duplications occurred mostly in South East
Asia,  indicating  that  regional  selective  pressures  have  a  significant  impact  on  the
retention of copy number variants. We identified numerous novel genic copy number
variants, one of which was a biallelic duplication of crt. This duplication is intriguing as
it  contains  both  a  chloroquine  resistant  and  a  chloroquine  sensitive  allele.  However,
overall, this global analysis indicates that copy number variation in the non-subtelomeric
regions is a rare event, however drug resistance is a major factor in the frequency and
genesis of these copy number variants.
5.2 Genes of extracellularly exposed proteins are highly duplicated in P. falciparum
Our segmental duplication analysis highlighted the extent of gene duplication for
117
genes  encoding  extracellularly  exposed  proteins.  The  overrepresentation  of  antigenic
genes under human immune pressure to the exclusion of other factors has resulted in a
highly  segregated  genome,  with  segmental  duplications  and the  subsequent  antigenic
factor  primarily  isolated  to  the  subtelomeric  regions,  with  the  rest  of  the  genome
containing  few segmental  duplications.  Meanwhile,  significant  selective  pressures  for
neogenesis and diversification of protein coding sequence is manifested in the significant
duplication and high nucleotide diversity of the subtelomeric genes.
This is not a circumstance unique to  Plasmodium falciparum, but is common in
multiple species in the  Plasmodium clade  [156, 157]. However, the exact repertoire of
genes encoding extracellularly exposed proteins under human immune pressure that are
duplicated differs between species  [158]. We can infer that the specific genes are not
responsible for the genesis of new duplications, but rather that the subtelomeric regions
are  regions  suitable  for  promotion  of  duplication  and  diversification  –  allowing  for
telomeric exchange without disrupting meiotic stability. Selective pressures for increased
antigenic  diversity  have  promoted  the  co-opting  of  these  regions  as  engines  of
diversification  for  particular  gene  families  unique  to  the  selective  pressures  of  each
plasmodium species [159–162].
Significant resources and study has been invested into the var gene family due to
its  relation  to  severe  symptoms  of  malaria  [160,  162].  However,  our  analysis  of
segmental  duplications  indicate  that  other  gene  families  may  have  equally  important
impact on the P. falciparum antigenic diversity and cytoadherence capabilities. The rifin
gene family has a larger contingent of genes than the var gene family, and shows similar
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rates of recombination. Neither gene family showed strong evidence for recent whole
gene duplications that has not already undergone significant nucleotide divergence.
In addition, the relative lack of segmental duplications outside the subtelomeric
regions  provides  insight  into  the  purpose  of  copy  number  variants  outside  the
subtelomeric regions and the reason for the bias toward a heavily duplicated subtelomere.
The lack of duplication of the core genome indicates a strong purifying selection against
duplication of genes not encoding extracellularly exposed proteins under human immune
pressure, as few have become fixed, resulting in maintenance of gene dosage balance.
This  indicates  that  future  copy number  variants  in  the  core  genome are  likely  to  be
present as adaptations for gene dosage. In particular, the gene dosage plays a pivotal role
in adaptation to drug resistance or metabolic necessity. However, the pressure to maintain
high  diversity  in  antigen  presenting  proteins  requires  significant  recombination  and
duplication of genes. This has resulted in the parasite co-opting a duplication favorable
region, the subtelomeres, to continually duplicate and recombine its large genes familes
of genes encoding extracellularly exposed proteins under human immune pressure while
preserving the conserved state of the rest of the genome.
5.3 Segmental duplications and high throughput sequencing
Currently,  the detection of copy number variation in the population requires a
high quality reference genome. However, our analysis of segmental duplications in the
genome highlight problematic regions for current means of analysis. It affects  de novo
graph-based  assemblies  due  to  collapse  of  high  identity  regions  into  single  contigs.
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Additionally, high identity duplicated regions are problematic for read alignment because
current alignment technologies cannot discern accurate placement of sequence-identical
regions,  resulting  in  misplacement  of  reads  during  alignment.  In  addition,  high
recombination rates within the subtelomeric regions create a unique subtelomeric genome
between  strains,  thereby  mitigating  the  relational  accuracy  of  the  reference  genome
subtelomeric regions to other strains in the species.
Both  the  effects  on  de  novo assembly  and  accurate  read  placement  have
significant  consequences  for  current  copy  number  variation  detection.  High  identity
regions prevent complete genome reproduction of de novo genome assemblies, reducing
the likelihood of detecting deletions and high identity duplications via de novo assembly.
In addition, the effects on read placement accuracy have effects on copy number variation
detection methods that require accurate read placement. Improper read placement due to
duplication and recombination will hamper methods involving both discordant reads and
read  depth.  For  this  reason,  our  analysis  of  copy number  variation  in  P.  falciparum
ignored nearly all regions we identified through our segmental duplication analysis. The
high rate of recombination and copy number variation in these regions prevents simply
adjusting  for  nucleotide  diversity  and  will  require  accurate  assembly.  Future
improvements  to  sequencing  technology  and  de  novo assembly  will  be  required  for
accurate copy number variation assessment in these regions.
5.4 Rapid and efficient copy number variation detection
Our novel computational method for copy number variation detection from next
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gen sequencing is the first study of copy number variation in a large natural population.
Considering our work with segmental duplications and the limitations of the methods
being applied, we could not investigate copy number variation in the regions identified as
segmental  duplications.  The long tracts  of  simple,  high  AT repeat  sequence  between
genes  and the  high nucleotide  diversity  of  genes  in  the  segmental  duplications  make
accurate  read  placement  and  de  novo assembly  of  the  region difficult.  However,  the
majority  of  the  genome is  still  available  to  investigate.  The  ability  to  identify  copy
number variants in a natural population is a major step forward in understanding the role
of copy number variation in P. falciparum.
The method we designed is rapid and specific. It also has a simple requirement of
a  single  next  gene  sequencing library.  Though  it  has  only  been tested  with  Illumina
sequencing at various read sizes, theoretically it should work with a number of next gen
sequencing platforms. Additionally, the program has modest read depth requirements –
working  at  10x  coverage.  The  low  read  depth  requirement  allows  multiplexing  of
multiple samples, further reducing the cost of surveying copy number variation across a
population.  The  rapidly  plunging  cost  of  next  gen  sequencing  and  the  modest
requirements of our copy number detection methodology bodes well  for the future of
copy number variation surveillance around the globe. We now have the capability to take
census  of  current  copy  number  variation  in  P.  falciparum and  identify  potential
adaptations via copy number variation from genome-wide scans, reducing the necessity
of targeted copy number variation detection methods.
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5.5 Extent of copy number variation in P. falciparum
From our study of lab strains alone, we found a significant fraction of the copy
number variants were correlated with drug resistance –  mdr1,  gch, and  dhfr. However,
our investigation into a global population of P. falciparum identified that drug resistance
still plays an important role in copy number variation. While our our initial foray into a
natural  population produced results  that  hinted at  a  staid and relatively copy number
invariant  genome compared to  many other  organisms  [5],  the  expansion  of  scope to
multiple other countries and geographic regions reinforced the idea that copy number
variation may be rare. From 610 samples across the globe, only 68 copy number variants
were identified.  When filtering  for  solely  genic  copy number  variants,  only  33  copy
number variants incorporated the entirety of a gene. However, the frequency of individual
instances  of  copy  number  variation  was  dominated  by  mdr1  and  gch duplications.
Furthermore, the frequency of these two copy number variants are regionally specific,
with nearly all identified in strains from South East Asia. Potentially, this could highlight
major differences in drug pressure between the two regions, in that South East Asia has
much higher drug pressure to have such high representation of drug resistance related
copy number variants.
The extent of copy number variation in P. falciparum is significantly impacted by
drug pressure.  The frequency of copy number variation remained low (<10%) unless
confronted with strong drug pressure. Nearly 50% of samples in South East Asia had at
least  one copy number  variation,  and that  copy number  variation  was  predominantly
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mdr1 or gch. However, there was little overlap between the two copy number variants.
This indicates that there is strong selective pressure to maintain the gene dosage balance
of the majority of the core genome, i.e. the genomic regions aside from the telomeres and
subtelomeres.  S. cerevisiae display a lack of compensation for increased protein levels
from gene duplication [163]. Comparatively, P. falciparum's lack of duplication indicate
that nutrient scarcity may be a strong driving force for selection against gene duplication.
Exacerbating  this  selection  against  increased  protein  levels  is  the  relative  lack  of
epigenetic  regulation.  Except  for  the  subtelomeric  regions,  most  of  the  genome  is
euchromatin [164–166]. This results in a lack of specific regulation of gene expression by
epigenetic factors. This lack of epigenetic control and low tolerance for protein level
increases results in a strong purifying selection against genic duplication.
5.6 Future direction for the investigation of duplications in P. falciparum
The  stark  contrast  between  the  prolific  duplication  and  deletion  of  the
subtelomeric regions of the genome and the paucity of duplications and deletions in the
rest of the genome indicates a strong purifying selection on the non-subtelomeric regions
of the genome. It  highlights that the observed copy number variation within the core
genome likely has significant functional consequence important to the parasite fitness.
This study identifies numerous such genes whose copy number variation has potential
functional consequence. Future research will hopefully identify the specific gene within
any copy number variant as the gene under selection. From there, studies to understand
the  potential  functional  significance  will  provide  insight  to  the  effects  of  these  copy
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number  variants  –  affecting  competitive  growth  advantages  over  other  parasites,
adaptation to human genetics, or drug resistance.
One copy number variant in particular will require significant research into its
effects  –  the  duplication  of  crt.  This  duplication  was  bialleic  for  both  chloroquine
resistant  and  chloroquine  sensitive  alleles  of  crt.  The  duplication  potentially  confers
significant  compensatory  adaptation  to  drug  resistance.  While  chloroquine  resistant
alleles confer significant growth disadvantages to the parasite, a duplication with both
sensitive and resistant alleles should have both the advantage of chloroquine resistance
and mitigated growth inhibition from said chloroquine resistant allele. The independent
verification of its existence in the population would prove the sensitivity and power of
our  computational  methods.  Also,  testing  the  hypothetical  benefits  of  the  biallelic
duplication  in  vitro for  IC50  drug  assays  and  growth  rate  assays  would  verify  the
potential advantages of the duplication. This has effects on future anti-malarial protocols,
potentially eliminating the viability of re-introduction of chloroquine as this duplication
could rapidly sweep across the population. It also has serious ramification in current and
future drug design strategies, as relying on the functional constraints for mutation of the
crt gene may be a strategic dead end.
With the high throughput sequence data and our identification of copy number
variants, future studies can identify the genesis of copy number variants. Multiple copy
number variants showed great variability in breakpoint and copy number. Study of the
haplotype and tracing historical recombination could illuminate the origin of these copy
number  variants.  Currently,  it  is  uncertain  whether  many  copy  number  variants  had
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multiple independent genesis events or whether the multiple isoforms of a copy number
variation  resulted  from  a  single  progenitor.  A comprehensive  analysis  of  haplotype
between copy number variant  isoforms,  both in  break  point  and copy number,  could
elucidate the genesis of various copy number variant isoforms. In addition, our method
can be used as a survey tool to rapidly and efficiently detect copy number variation in a
population of P. falciparum. This allows study of demographic evolution of copy number
variation in the population and the identification of novel copy number variants as they
arise. Both the understanding of the genesis of copy number variants, their proliferation,
and consistent  survey of populations for copy number variation can help monitor for
emerging drug resistance and inform best practices for anti-malarial regimens.
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Appendix Table 1 Identified Copy Number Variants
Chrom Position Length Sampling site Sample ID
chr01 238445 - 248349 9,905 2.16 Gambia 374
chr01 549500 - 640851 91,352 0.00 Senegal SenP27.02
chr01 563800 - 640851 77,052 0.00 Senegal SenT10.04D10
chr01 551800 - 554000 2,201 0.00 Senegal SenT32.09
chr02 220981 - 238374 17,394 2.02 Cambodia (Ratanakiri) 286
chr02 355068 - 356081 1,014 2.02 Thailand 796
chr02 555458 - 662357 106,900 1.66 Gambia 403
chr02 671115 - 672530 1,416 2.01 Thailand 766
chr02 835300 - 947102 111,803 0.00 Senegal SenT090.09
chr02 863500 - 947102 83,603 0.00 Senegal SenT135.09
chr03 128244 - 134634 6,391 0.13 Ghana 477
chr03 251527 - 252914 1,388 3.84 Thailand 766
chr03 663859 - 664651 793 2.21 Gambia 374
chr03 984410 - 985091 682 2.61 Cambodia (Pursat) 136
chr04 250530 - 349000 98,471 1.95 Gambia 407
chr05 388213 - 390121 1,909 0.41 Ghana 477
chr05 441610 - 461650 20,041 1.48 Cambodia (Pursat) 218
chr05 446993 - 462053 15,061 1.56 Ghana 574
chr05 448740 - 460238 11,499 1.70 Cambodia (Ratanakiri) 248
chr05 505687 - 506365 679 2.28 Ghana 477
chr05 670907 - 770083 99,177 1.83 Gambia 407
chr05 870787 - 978366 107,580 3.58 Cambodia (Pursat) 122
Copy 
number
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chr05 943270 - 970993 27,724 2.03 Cambodia (Pursat) 126
chr05 943344 - 964658 21,315 2.11 Cambodia (Pursat) 168
chr05 944490 - 973296 28,807 2.07 Cambodia (Pursat) 178
chr05 944894 - 964526 19,633 3.15 Thailand 811
chr05 945099 - 964624 19,526 2.00 Cambodia (Pursat) 114
chr05 946149 - 973288 27,140 1.91 Cambodia (Pursat) 150
chr05 946483 - 967340 20,858 3.08 Cambodia (Pursat) 127
chr05 946485 - 964658 18,174 3.11 Cambodia (Pailin) 56
chr05 946487 - 964647 18,161 2.94 Cambodia (Pailin) 63
chr05 946488 - 964640 18,153 3.09 Cambodia (Pailin) 79
chr05 946488 - 964652 18,165 3.07 Cambodia (Pursat) 207
chr05 946558 - 964629 18,072 2.03 Cambodia (Pursat) 101
chr05 947121 - 963187 16,067 2.10 Thailand 778
chr05 947579 - 962565 14,987 2.02 Thailand 774
chr05 947636 - 962557 14,922 2.82 Thailand 721
chr05 947773 - 969928 22,156 3.23 Cambodia (Pursat) 153
chr05 947774 - 969926 22,153 2.09 Cambodia (Pursat) 131
chr05 947781 - 969907 22,127 1.91 Cambodia (Tasanh) 313
chr05 947785 - 969917 22,133 2.01 Cambodia (Tasanh) 337
chr05 948114 - 970296 22,183 1.47 Cambodia (Tasanh) 315
chr05 950684 - 972006 21,323 3.12 Thailand 759
chr05 952701 - 970350 17,650 2.13 Cambodia (Pursat) 118
chr05 953745 - 970361 16,617 3.04 Thailand 769
chr05 953747 - 970349 16,603 2.12 Thailand 764
chr05 953794 - 972127 18,334 3.82 Thailand 756
chr05 953827 - 970299 16,473 2.94 Cambodia (Pursat) 116
chr05 953828 - 970293 16,466 3.14 Cambodia (Pursat) 112
chr05 953843 - 970259 16,417 2.33 Cambodia (Pursat) 109
chr05 953870 - 970299 16,430 3.04 Cambodia (Pursat) 102
chr05 953871 - 970285 16,415 2.62 Cambodia (Pursat) 103
chr05 953894 - 970289 16,396 2.69 Thailand 812
chr05 962655 - 963279 625 2.41 Kenya ERS010407
chr06 485029 - 485675 647 2.06 Gambia PA0068-C
chr06 492315 - 503056 10,742 1.62 Thailand 778
chr06 849764 - 850377 614 2.40 Mali 677
chr06 1117358 - 1119225 1,868 2.04 Senegal SenT033.09
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chr06 1117364 - 1119201 1,838 2.11 Guinea PA0186-C
chr06 1117368 - 1119193 1,826 2.03 Senegal SenT086.09
chr06 1117369 - 1119203 1,835 2.40 Guinea PA0245-C
chr06 1117371 - 1119206 1,836 2.89 Guinea PA0208-C
chr06 1117373 - 1119156 1,784 1.94 Guinea PA0140-C
chr06 1117376 - 1119225 1,850 2.13 Senegal SenT148.09
chr06 1117379 - 1119205 1,827 3.07 Guinea PA0180-C
chr06 1117380 - 1119204 1,825 2.02 Guinea PA0234-C
chr06 1117381 - 1119204 1,824 1.97 Senegal SenT142.09
chr06 1117385 - 1119187 1,803 2.23 Guinea PA0157-C
chr06 1117385 - 1119193 1,809 2.20 Guinea PA0169-C
chr06 1117397 - 1119202 1,806 2.44 Thailand 730
chr06 1117399 - 1119209 1,811 2.35 Cambodia (Ratanakiri) 290
chr06 1117399 - 1119202 1,804 2.83 Gambia 367
chr06 1117399 - 1119211 1,813 1.98 Mali 679
chr06 1117399 - 1119204 1,806 2.09 Cambodia (Pailin) 73
chr06 1117399 - 1119202 1,804 2.06 Thailand 769
chr06 1117399 - 1119186 1,788 3.24 Thailand 765
chr06 1117400 - 1119206 1,807 2.94 Cambodia (Pursat) 202
chr06 1117400 - 1119200 1,801 2.38 Thailand 772
chr06 1117400 - 1119207 1,808 2.19 Cambodia (Ratanakiri) 269
chr06 1117400 - 1119199 1,800 1.92 Thailand 764
chr06 1117400 - 1119016 1,617 2.24 Cambodia (Pursat) 150
chr06 1117400 - 1119198 1,799 2.12 Thailand 767
chr06 1117400 - 1119185 1,786 2.60 Ghana 590
chr06 1117401 - 1119202 1,802 1.95 Cambodia (Pursat) 163
chr06 1117401 - 1119195 1,795 2.27 Cambodia (Pursat) 199
chr06 1117401 - 1119201 1,801 2.05 Cambodia (Pursat) 166
chr06 1117401 - 1119191 1,791 2.00 Cambodia (Tasanh) 315
chr06 1117401 - 1119199 1,799 2.13 Thailand 760
chr06 1117402 - 1119206 1,805 2.02 Cambodia (Pursat) 227
chr06 1117402 - 1119202 1,801 2.01 Cambodia (Pailin) 56
chr06 1117402 - 1119204 1,803 2.60 Cambodia (Pursat) 178
chr06 1117402 - 1119200 1,799 2.09 Cambodia (Pursat) 225
chr06 1117402 - 1119202 1,801 2.25 Thailand 775
chr06 1117403 - 1119187 1,785 2.04 Cambodia (Tasanh) 318
chr06 1117403 - 1119195 1,793 1.99 Thailand 759
chr06 1117403 - 1119204 1,802 2.01 Thailand 768
chr06 1117403 - 1119188 1,786 2.02 Cambodia (Tasanh) 316
chr06 1117404 - 1119201 1,798 2.30 Thailand 763
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chr06 1117404 - 1119191 1,788 2.09 Cambodia (Tasanh) 328
chr06 1117404 - 1119200 1,797 2.24 Cambodia (Pursat) 204
chr06 1117404 - 1119203 1,800 2.37 Cambodia (Pursat) 203
chr06 1117404 - 1119187 1,784 2.01 Cambodia (Tasanh) 335
chr06 1117404 - 1119201 1,798 2.27 Cambodia (Tasanh) 331
chr06 1117405 - 1119200 1,796 1.97 Cambodia (Pursat) 180
chr06 1117405 - 1119198 1,794 1.97 Thailand 753
chr06 1117405 - 1119204 1,800 2.14 Cambodia (Pursat) 169
chr06 1117406 - 1119174 1,769 2.26 Cambodia (Pursat) 205
chr06 1117406 - 1119186 1,781 4.02 Cambodia (Tasanh) 325
chr06 1117407 - 1119199 1,793 2.28 Cambodia (Tasanh) 336
chr06 1117407 - 1119206 1,800 2.21 Cambodia (Pursat) 164
chr06 1117407 - 1119175 1,769 2.36 Cambodia (Tasanh) 314
chr06 1117408 - 1119197 1,790 2.01 Cambodia (Tasanh) 312
chr06 1117412 - 1119128 1,717 2.17 Cambodia (Tasanh) 327
chr06 1117413 - 1119198 1,786 1.99 Thailand 762
chr06 1117418 - 1119019 1,602 2.30 Thailand 778
chr06 1117418 - 1119131 1,714 1.91 Senegal SenP51.02
chr06 1117424 - 1119151 1,728 2.51 Cambodia (Tasanh) 326
chr06 1117434 - 1119149 1,716 2.26 Guinea PA0214-C
chr06 1117438 - 1119192 1,755 2.87 Cambodia (Pailin) 76
chr06 1117484 - 1119158 1,675 2.16 Cambodia (Pursat) 105
chr06 1117485 - 1119195 1,711 2.26 Guinea PA0225-C
chr06 1117486 - 1119130 1,645 2.17 Cambodia (Pursat) 104
chr06 1117487 - 1119162 1,676 3.04 Cambodia (Pursat) 115
chr06 1117488 - 1119162 1,675 3.13 Cambodia (Pursat) 108
chr06 1117489 - 1119152 1,664 2.22 Cambodia (Pursat) 110
chr06 1117598 - 1119095 1,498 2.09 Cambodia (Tasanh) 333
chr06 1117624 - 1119095 1,472 2.12 Ghana 565
chr06 1117746 - 1119167 1,422 2.34 Ghana 525
chr06 1117766 - 1119181 1,416 2.11 Guinea PA0219-C
chr06 1117827 - 1119194 1,368 2.36 Cambodia (Ratanakiri) 262
chr07 394657 - 421919 27,263 1.91 Burkina Faso 43
chr07 398667 - 421914 23,248 1.91 Guinea PA0193-C
chr07 398674 - 421912 23,239 1.83 Ghana 590
chr07 398676 - 421917 23,242 2.06 Ghana 520
chr07 398678 - 421912 23,235 1.98 Ghana 489
chr07 398679 - 421905 23,227 2.21 Burkina Faso 47
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chr07 779132 - 796453 17,322 1.42 Cambodia (Pursat) 227
chr07 838352 - 888689 50,338 1.83 Gambia 403
chr07 1071568 - 1072232 665 2.21 Kenya ERS010453
chr08 1314610 - 1315703 1,094 2.01 Gambia PA0092-C
chr09 321465 - 322688 1,224 2.00 Gambia 372
chr09 1095691 - 1096396 706 2.91 Mali 661
chr09 1196177 - 1272137 75,961 1.43 Gambia PA0100-C
chr09 1226756 - 1251976 25,221 1.44 Cambodia (Pursat) 226
chr09 1240368 - 1251255 10,888 1.49 Cambodia (Pursat) 218
chr09 1377600 - 1541735 164,136 0.00 Senegal SenT10.04D10
chr09 1379800 - 1541735 161,936 0.00 Senegal SenT137.09
chr09 1385500 - 1541735 156,236 0.00 Senegal SenT002.09
chr09 1387200 - 1541735 154,536 0.00 Senegal SenT113.09
chr09 1387700 - 1541735 154,036 0.00 Senegal SenT021.09
chr09 1469100 - 1541735 72,636 0.00 Senegal SenT15.04
chr09 1384812 - 1385890 1,079 0.22 Cambodia (Pursat) 168
chr09 1397601 - 1399000 1,400 0.18 Senegal SenP27.02
chr09 1397755 - 1399113 1,359 0.07 Cambodia (Pursat) 101
chr09 1397756 - 1399122 1,367 0.23 Cambodia (Pursat) 105
chr09 1397758 - 1399124 1,367 0.24 Cambodia (Pursat) 104
chr09 1397762 - 1399109 1,348 0.31 Cambodia (Pursat) 110
chr09 1397763 - 1399115 1,353 0.16 Cambodia (Pursat) 117
chr09 1397764 - 1399111 1,348 0.13 Cambodia (Pursat) 113
chr09 1397764 - 1399114 1,351 0.19 Cambodia (Pursat) 116
chr09 1397768 - 1399118 1,351 0.25 Cambodia (Pursat) 115
chr09 1397790 - 1399132 1,343 0.02 Thailand 807
chr09 1397792 - 1399116 1,325 0.12 Cambodia (Pursat) 108
chr09 1397796 - 1399114 1,319 0.21 Cambodia (Pursat) 111
chr09 1397801 - 1399100 1,300 0.22 Senegal SenT15.04
chr09 1397812 - 1399134 1,323 0.15 Thailand 796
chr09 1397824 - 1399117 1,294 0.14 Cambodia (Pursat) 109
chr09 1397839 - 1399122 1,284 0.18 Cambodia (Pursat) 107
131
chr09 1397843 - 1399125 1,283 0.23 Thailand 803
chr09 1397901 - 1399000 1,100 0.11 Senegal SenT127.09
chr09 1397901 - 1399000 1,100 0.17 Senegal SenT231.08
chr09 1397901 - 1399000 1,100 0.13 Senegal SenT74.08
chr09 1397901 - 1399000 1,100 0.09 Senegal SenT135.09
chr09 1397901 - 1399200 1,300 0.13 Senegal SenT123.09
chr09 1397901 - 1399200 1,300 0.18 Senegal SenT130.09
chr09 1397901 - 1399200 1,300 0.20 Senegal SenT032.09
chr09 1397901 - 1399300 1,400 0.20 Senegal SenT230.08
chr09 1397901 - 1399300 1,400 0.22 Senegal SenV42.05
chr09 1407201 - 1408300 1,100 0.40 Senegal SenT128.09
chr10 903354 - 904074 721 2.52 Cambodia (Pursat) 159
chr10 1170378 - 1174324 3,947 2.43 Gambia 374
chr10 1376686 - 1440190 63,505 3.04 Senegal SenT151.09
chr10 1424265 - 1425505 1,241 2.07 Gambia PA0071-C
chr11 461088 - 493610 32,523 0.16 Gambia 403
chr11 687757 - 688583 827 2.08 Mali 678
chr11 814857 - 868533 53,677 1.41 Gambia PA0101-C
chr11 821011 - 845503 24,493 1.60 Mali 677
chr11 1054820 - 1059223 4,404 0.16 Burkina Faso 44
chr11 1054851 - 1059280 4,430 0.43 Mali 666
chr11 1054935 - 1059247 4,313 0.44 Mali 676
chr12 461869 - 462612 744 2.37 Kenya ERS010455
chr12 822219 - 830842 8,624 3.04 Cambodia (Ratanakiri) 290
chr12 903997 - 1023825 119,829 1.81 Cambodia (Pursat) 239
chr12 934736 - 975016 40,281 1.59 Cambodia (Pursat) 121
chr12 936352 - 936993 642 7.90 Kenya ERS017455
chr12 941097 - 980769 39,673 4.29 Cambodia (Pailin) 80
chr12 967737 - 978066 10,330 1.91 Cambodia (Pursat) 171
chr12 968639 - 978077 9,439 2.69 Thailand 763
132
chr12 968640 - 978085 9,446 10.50 Thailand 711
chr12 968643 - 980646 12,004 2.91 Cambodia (Pursat) 168
chr12 968643 - 978084 9,442 5.80 Thailand 757
chr12 968646 - 978080 9,435 1.91 Thailand 767
chr12 968647 - 978079 9,433 1.93 Cambodia (Pursat) 167
chr12 968649 - 978078 9,430 1.73 Thailand 755
chr12 968649 - 978073 9,425 3.48 Thailand 766
chr12 968650 - 978077 9,428 1.81 Cambodia (Pursat) 231
chr12 968651 - 978079 9,429 1.67 Cambodia (Pursat) 208
chr12 968656 - 978087 9,432 2.20 Thailand 710
chr12 968659 - 978078 9,420 1.69 Cambodia (Pursat) 159
chr12 968661 - 978072 9,412 1.94 Cambodia (Pursat) 211
chr12 968672 - 976316 7,645 6.09 Thailand 762
chr12 968676 - 976313 7,638 2.89 Thailand 760
chr12 968677 - 978083 9,407 1.69 Cambodia (Pursat) 216
chr12 968678 - 976310 7,633 1.95 Thailand 753
chr12 968678 - 978079 9,402 1.98 Cambodia (Pursat) 165
chr12 968693 - 978077 9,385 1.85 Cambodia (Pursat) 244
chr12 968696 - 978076 9,381 2.91 Thailand 730
chr12 968698 - 976310 7,613 2.97 Ghana 478
chr12 968699 - 978077 9,379 4.58 Thailand 716
chr12 968701 - 976319 7,619 6.18 Thailand 761
chr12 968702 - 978079 9,378 1.95 Cambodia (Pursat) 169
chr12 968704 - 978076 9,373 1.82 Cambodia (Pursat) 197
chr12 968709 - 978076 9,368 2.52 Cambodia (Pailin) 76
chr12 968711 - 978073 9,363 2.03 Thailand 733
chr12 968720 - 976305 7,586 2.22 Thailand 714
chr12 968729 - 978068 9,340 2.14 Cambodia (Pursat) 120
chr12 968730 - 976273 7,544 1.98 Ghana 525
chr12 968773 - 978045 9,273 3.00 Thailand 805
chr12 968777 - 978045 9,269 2.69 Cambodia (Pursat) 111
chr12 968779 - 978041 9,263 2.77 Thailand 809
chr12 968779 - 976281 7,503 3.91 Thailand 803
chr12 968780 - 978042 9,263 3.26 Cambodia (Pursat) 104
chr12 968794 - 978040 9,247 2.85 Thailand 810
chr12 968884 - 978063 9,180 3.16 Thailand 720
chr12 973602 - 974374 773 2.24 Guinea PA0177-C
chr12 973608 - 976162 2,555 2.23 Cambodia (Pursat) 152
chr12 973609 - 976160 2,552 2.77 Thailand 769
chr12 973611 - 976157 2,547 2.05 Ghana 541
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chr12 973612 - 976139 2,528 8.84 Thailand 778
chr12 973612 - 976162 2,551 3.01 Thailand 764
chr12 973613 - 976144 2,532 9.25 Thailand 774
chr12 973613 - 975920 2,308 2.23 Ghana 543
chr12 973615 - 974272 658 2.21 Kenya ERS010641
chr12 973615 - 976154 2,540 2.02 Ghana 540
chr12 973621 - 976147 2,527 1.97 Ghana 565
chr12 973625 - 974362 738 1.94 Guinea PA0201-C
chr12 973628 - 976117 2,490 2.45 Thailand 759
chr12 973639 - 974364 726 2.07 Guinea PA0158-C
chr12 973645 - 976138 2,494 2.52 Thailand 775
chr12 1073984 - 1075014 1,031 1.99 Cambodia (Pailin) 55
chr12 1267185 - 1309576 42,392 1.57 Gambia PA0100-C
chr12 1268398 - 1296032 27,635 1.47 Gambia PA0101-C
chr12 1274036 - 1293832 19,797 1.66 Cambodia (Pursat) 121
chr12 1542242 - 1542923 682 2.06 Kenya ERS010452
chr12 1657036 - 1680085 23,050 1.59 Ghana 477
chr12 1767965 - 1769423 1,459 2.26 Ghana 477
chr13 452231 - 453006 776 4.03 Kenya ERS017455
chr13 965987 - 969833 3,847 0.24 Ghana 459
chr13 1068874 - 1084103 15,230 1.45 Cambodia (Pursat) 221
chr13 1154958 - 1183794 28,837 1.46 Cambodia (Pursat) 221
chr13 1162411 - 1181184 18,774 1.62 Cambodia (Pursat) 159
chr13 1200973 - 1201602 630 5.92 Kenya ERS017455
chr13 1212379 - 1264030 51,652 1.90 Gambia 407
chr13 1423943 - 1449811 25,869 2.06 Kenya ERS010454
chr13 1430177 - 1449822 19,646 2.23 Kenya ERS010455
chr13 1428865 - 1429987 1,123 0.34 Gambia PA0068-C
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chr13 1428908 - 1429972 1,065 0.32 Mali 688
chr13 1428953 - 1429975 1,023 0.31 Ghana 515
chr13 1429053 - 1429993 941 0.27 Ghana 575
chr13 1429079 - 1429975 897 0.34 Burkina Faso 13
chr13 2623768 - 2624384 617 13.80 Kenya ERS017455
chr14 95794 - 109934 14,141 2.12 Cambodia (Pursat) 150
chr14 282835 - 300646 17,812 1.86 Cambodia (Pursat) 165
chr14 282842 - 300646 17,805 1.88 Cambodia (Pursat) 169
chr14 289091 - 298886 9,796 3.12 Cambodia (Pursat) 198
chr14 289396 - 298896 9,501 2.32 Cambodia (Pursat) 129
chr14 289401 - 298894 9,494 3.58 Cambodia (Pursat) 194
chr14 289401 - 298889 9,489 1.99 Cambodia (Pursat) 199
chr14 289402 - 298900 9,499 1.68 Cambodia (Pursat) 180
chr14 289402 - 298898 9,497 1.68 Cambodia (Pursat) 218
chr14 289405 - 298895 9,491 1.74 Cambodia (Pursat) 227
chr14 289407 - 298885 9,479 2.62 Cambodia (Tasanh) 320
chr14 289407 - 298894 9,488 1.74 Cambodia (Pursat) 215
chr14 289408 - 298875 9,468 2.06 Cambodia (Tasanh) 318
chr14 289409 - 298886 9,478 1.71 Cambodia (Pursat) 173
chr14 289409 - 298869 9,461 2.01 Cambodia (Tasanh) 336
chr14 289411 - 298888 9,478 1.83 Cambodia (Pursat) 163
chr14 289417 - 298882 9,466 1.83 Cambodia (Tasanh) 317
chr14 289421 - 298893 9,473 1.81 Cambodia (Tasanh) 325
chr14 367404 - 368300 897 1.94 Kenya ERS017458
chr14 589978 - 592404 2,427 2.61 Guinea PA0200-C
chr14 695480 - 704797 9,318 1.55 Thailand 775
chr14 1099777 - 1101133 1,357 0.45 Mali 677
chr14 1152175 - 1259839 107,665 1.73 Gambia 403
chr14 1185390 - 1186146 757 2.37 Gambia 382
chr14 1185425 - 1186197 773 2.94 Burkina Faso 7
135
chr14 1733015 - 1748645 15,631 1.99 Gambia 374
chr14 1734101 - 1735000 900 0.24 Senegal SenT021.09
chr14 2020371 - 2021382 1,012 2.74 Kenya ERS010454
chr14 2257914 - 2259309 1,396 2.78 Cambodia (Pursat) 125
chr14 2620036 - 2620833 798 2.14 Gambia 374
chr14 2698050 - 2699156 1,107 2.44 Thailand 766
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